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INTRODUCTION 
Siddha system of medicine is one of the oldest systems of  medicine practiced in 
South India especially in Tamil Nadu. It is a traditional system of medicine which is 
gradually evolved along with the Dravidians culture and hence this system is known as 
Dravidian system of medicine. 
The term „Siddha‟ means achievements and Siddhars were saintly persons who 
achieved results in medicine. The Siddhars were great scientist in ancient times. 
Eighteen Siddhars were said to have contributed towards the development of this 
medical system.   
According to tradition, the origin of Siddha system of medicine is attributed  to 
the great Siddha Agasthiyar, 
There are certain diseases that can be cured. Some diseases, that can only be 
managed. But it always best that they can be prevented. 
“kWg;g Jly; Neha; kUe;njd yhFk; 
 kWg;g Js Neha; kUe;njd rhYk; 
 kWg;g jpdp Neha; thuh jpUg;g 
 kWg;gJ rhit kUe;njd yhNk.” 
                                -jpUke;jpuk; 
The Siddha System  of Medicine emphasizes that medical treatment is oriented 
not merely to disease but  also it has to be taken into account the patient‟s physical 
condition, environments,  physiological constitution etc. This means the treatment has 
to be individualistic and tailor-made which ensures that mistakes in diagnosis or 
treatment are minimal. 
This system is mainly based on „Andapinda Thathuvam‟„Panchaboothas‟. The 
structural aspect of human body is said to be „Udal Thathus‟ (ie. The physical 
component of the human body) and the functional units of the human body is said to 
be‟Uyir Thathus‟ or Three humours (the physiological unit ie., Vatham, Pitham, 
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Kapham). Functional cooperation of these two are essential for the maintainence of 
health. 
Even though the treatment is based upon „Thridosha theory‟ the diagnosis is 
based upon „Envagai thervu‟ which includes Naa, Niram, Mozhi, Vizhi, Malam, 
Moothiram, Naadi and Sparism. 
Health is considered as the maintance of equilibrium between the three humours 
and the diseases are imbalance among them. Some preventive measures are also clearly 
mentioned in siddha system. Among these diet plays a major role.              
Siddhar classified 4,448 types of disease. Within that Paandu Noi or Veluppu 
Noi is one of the diseases commonly affecting women and young children. 
In our country Nutritional Iron Deficiency is the most common cause of 
anaemia. „Iron Deficiency Anaemia‟(IDA) is a very common disease prevalent in the 
society. Long term oral iron therapy is commonly used as first line therapy but iron 
salts such as ferrous sulphate are associated with a high incidence of gastrointestinal 
side effects such as nausea, vomiting, diarrhoea or constipation. Because of their 
adverse effects, a safe, effective, cheap, and easily available drug is needed. Many 
drugs are available in Siddha system of medicine which have remarkable effects in 
treating anaemia. One such medicine is Chitramutti Nei indicated for anaemia 
mentioned in Siddha classical literature. It is also indicated for fever, jaundice and 
dropsy.Medicine is in the form ghee, it act as demulcent,have high nutritive value and 
helpful in absorption of iron and gainig weight in children.  
 With the aim of that, this Poly Herbal preparation may be effective to manage 
childhood IDA without any synergistic effects. The present study was carried out to 
study the efficacy and safety of the Siddha poly herbal compound  Chitramutti Nei 
with the application of modern parameters.   
 
 
 
3 
 
 
 
AIM AND OBJECTIVES 
AIM: 
The aim of this study on „Paandu Noi‟ is to ensure a new approach for 
diagnosis  and to find out a safe and effective remedy. 
 „Paandu Noi‟ is an important Haematological entity described in Siddha 
literatures. It is essential to find out a simple drug to overcome this disease. The drug  
should be easily available, economic, easily administered and also effective in smaller 
doses.  Chitramutti Nei possess all the above characters. This is the reason for selecting 
this drug.  
OBJECTIVES: 
1. To collect the literature of both Siddha and Modern aspects of the disease 
Paandu Noi. 
2. To have an idea about the prevalence of Paandu Noi with reference to age, 
sex, socio –economic status, poverty, seasonal variations etc. 
3. To know the aetiology, classification, symptoms, diagonostic methods    and 
line of treatment compared with Iron Deficiency Anaemia.   
4. To know the alteration of the disease under the topics Mukkutram, Udal 
Kattukal, Poripulangal, Envagai Thervukal, Neerkuri, Neikuri. 
5. To make a clinical trial on patients with the trial medicine Chitramutti Nei in 
the treatment of „ Paandu Noi‟. 
6. To make use of Modern parameters in the investigation side to confirm the 
diagnosis and to follow the progress of the patients. 
7. To elicit Biochemical analysis and Toxicological analysis Pharmacological 
action of the trial medicine. 
8. To make an awareness among the parents about the prevention of disease in 
children. 
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REVIEW OF LITERATURE 
SIDDHA ASPECTS 
PAANDU NOI 
The Siddha system of medicine is not only showing interest in the art of healing 
but, also given importance to the art of living. 
 This disease “Paandu Noi” is as old as the evening star. „Paandu‟  has its 
historical importance. The word “Paandu Noi” has been derived from“Hindu Epic 
Mahabharatham”where, the five heroes “Panja Pandavars” father is „Paandu‟. 
            It is said that this man, when born was very pale. Like Paandu Maharaja 
people who suffer by anaemia are pale in colour. So the disease named as Paandu Noi. 
VERU PEYARKAL (SYNONYMS): 
Veluppu noi, Venmai noi, Venpaandam. 
IYAL (DEFINITION): 
      Njfj;jpd; ,uj;jj;jpy; cs;s rpte;j mZf;fs; Fiwe;J Njfk; 
ntSj;JtpLtjw;F ghz;L Neha; vd;W ngaH. 
                                 -mfj;jpaH itj;jpa gps;isj;jkpo;  
The great siddhar Agasthiyar defined Paandu Noi in following verses: 
          “fopthFe;j Njfkg;gh fhzj;jr tj;jha; 
Tw;wptpL kd;dthry; Nfl;fpy; 
gopfhuH Kfj;jpy; KopahH NghNy ghz;lnky;yhk; 
ntSf;fbj;J uj;jk;” 
                    -mfj;jpaH itj;jpa fhtpak;  
                    Page no: 41 
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          As per the above literature Paandu Noi is a condition characterized by pallor of 
the conjunctivae, nail buds and body due to reduction of the red blood cell volume. 
          “Njfj;jpy; ,uj;jk; tw;wpj; 
     jPq;fhd tpe;j Neha; fhZkg;gh” 
                             -mfj;jpaH Fzthflk; 
                                 Page no: 6  
Pathartha Chindamani Status That: 
    “thnkd;w Nkdpnay;yhk; kQ;rspj;J kfhntSg;G 
cz;lhfp ke;jf; fz;zha;” 
                           -gjhHj;j Fzrpe;jhkzp 
                                                                  Page no: 272 
Noi Varum Vazhi (Etiology): 
Aeitiological factors were mentioned by different siddhars. It includes food habits, life 
styles, morality etc. 
According to Balavagadam , 
           “gpwe;jehs; gps;isf;Fj; jhNd ed;wha; 
gpjhthNy gpzpAlypd; NkNy Njhd;Wk; 
fdyJ nkj;j fhZk; fz;ZJ 
ntSf;F jhNd ntSj;jpL KjLjhDk;” 
                            -ghythflk;. 
Paandu noi may be inherited from the parents. It may be due to genetic factors.  
According to Yugi Vaithiya Chinthamani – 800 the causes of Veluppu are as follow 
                             “mwpe;JNk cw;gj;jp nrhy;yf; Nfsha; 
               Mjprhu kykpsfp nae;Neue;jhd; 
               ghpe;JNk GspAg;G ngUj;jyhYk;   
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ngj;jkh kf;fdpap Ue;jhYk; 
kpwpe;JNk jhk;G+y kpf mUe;jyhYk; 
kPwpNa kJf;fisj; jhd; Grpj;jyhYk; 
gwpe;JNk gfy; epj;jpiu nra;jhYk; 
ghz;L te;J ghhpYs;Nshh; gLk; ghlhNk.” 
                     -A+fp itj;jpa rpe;jhkzp 
Frequent attack of diarrhea, excessive intake of salt and sour food, living in hot 
surroundings, excessive chewing of pan and nuts, excessive sleeping in daytime are 
some of the behaviours causing Veluppu Noi.     
According to Thanvanthiri Vaithyam,  
 “jpUe;jpLk; ghz;L NuhfQ; Nrh;e;jpLq; Fzj;ijf; Nfsha;                    
 ,Ue;jpLk; thj gpj;jr; rpNyw;gd kpitjhd; khWk; 
 ghpe;Jjh ndhd;Nwhb nlhd;W nghUe;JtjhYk; kz;NzlUe;J 
 Mfpa %ye; jd;dp yide;jTl; lzj;jpdhYe; 
 Njhifah; Nkfj;jhYk; Jah;kpF Nrhfj;jhYe; 
 NjfNgh apid As;Nshh;f;Fe; jhpj;jpuQ; Nrh;jyhYk; 
 Ntfkhfe; jphpNjh\q;fs; kpQ;rpNa ghz;LthNk 
                        -jd;te;jphp itj;jpak; 
                                                                     Page no: 340 
         Imbalance between the vatham pitham and kabam, eating food along with mud, 
accumulation of excessive heat, excessive sarrow, poverty and psychological factors 
may cause the disease Paandu Noi. 
According to Thanvanthiri Vaithyampart II says that: 
   “Va;e;j Tl;bdf; fhyj;jpy; vOk;gpLk; gpj;je;jd;dpy; 
  tha;j;jpLk; cg;Gg;Gspg;G khpre;jh ndDk; gjhh;j;jk; 
  Nrh;e;Jgpj; je;jhd; nfl;L rpNyw;gdk; nghUe;jpj; Njf;fpw; 
  gha;e;J tz;zj;jid nfLf;Fk; gapj;jpak; ghz;LthNk” 
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                                                                            Page no: 341 
      When the pitha increased in hot seasons due to increase intake of salt, sour and 
pepper, increased pitha will deranged kabha and destroys the complexion of skin and 
results the Paandu Noi.    
According to Agasthiyar Gunavagadam, 
“nfhs;slh mgf;Ft Nghrdj;jhYk; 
Fb nfLj;J……………fpuhzpahYk; 
fs;slh fUg;gj;jpd; fpue;jpahYk; 
fdkhd ,uj;jj;jpd; Nghf;fpdhYk; 
md;dlh mjpahk ftdj;jhYk; 
mstw;w tprhue;jh dilAk; NghJk; 
njs;sNt Njfj;jpy; ,uj;jk; nfl;L 
njspthd ghz;Ljt Kz;lhk; ghNu” 
                    -mfj;jpah; Fzthflk; 
                                                                      Page no: 6 
Imperfectly cooked food, negligence in the treatment of diarrhea, profuse 
bleeding, excessive sarrow leads to Paandu Noi. 
According to Guru Naadi, 
                             “taujdpw; G+ehf jd;id rhh;e;J 
tUe;jpaJ Gw;WNghw;g; gw;wp fhZk; 
vOk;gpaJ fpUkpjh tpile;J Gf;fpy; 
,ay;ngUFq; Fly;kltha; nrhy;yf; NfS 
                                                         Page no: 331 
Pathological blood loss may occur due to various causes, one among them is 
worm infection which leads to chronic blood loss from the intestine hence causes 
Anaemia. 
 “fpUkpahy; te;jNjhlk; ngUfTz;L 
 Nfl;fyjpd; gphptjid fpukkhf  
 nghUkp tUk; thAnty;yq; fpUkpahNy 
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      GOf;fb Nghy; fhZkJ fpUkpahNy 
      nrUkptUk; gTj;jpuq;fs; fpUkpahNy 
      Njfkjpy; Nrhif Fl;lk; fpUkpahNy 
                                                         Page no: 333 
According to this,‟ sobai‟ will occur due to worm infestation, which meant Paandu 
Noi.  
According to Agasthiyar Paripoooranam -400 , 
                    “ey;Nyhh;fs; nghpNahh;fs; elj;JQ; nra;if 
ehl;bYs;s Jh;Fzq;fs; eifj;jhNy 
nghy;yhj tp\ePh; gw;wp te;J  
Njfnky;yhk; F\;lk; NghyNt  
nrhy;yhj fb tp\q;fs; Fd;kk; ghz;L” 
                                                                   Page no: 78 
      Here it is explained that paandu and other diseases occur due to the toxic substances 
produced in the body by their unhealthy lifestyle. 
Due to toxic  
   “gj;jpd apuj Njhlk; ghz;Lthk; Nkdp nay;yhk;” 
Due to impure mercury, over dose of phosphorus, lead, copper sulphate and chronic use 
of white arsenic produce the synptoms of Paandu. 
NOI ENN (CLASSIFICATION): 
According to Baalavaagadam Paandu Noi is classified into 3 types, 
 Vaatha paandu, Pitha paandu, Kaba paandu. 
CLASSIFICATION OF PAANDU NOI BASED ON VARIOUS SIDDHA BOOKS: 
According to Yugimuni Paandu noi is classified into 5 types 
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            “$wNt ghz;Ltplg; ngaiuf; Nfsha; 
      Fwpg;ghf ite;Jtpj khFk; ghU 
  thuNt thjkhk; ghz;b NdhL 
                    khh;fkhk; gpj;jj;jpd; ghz;L jhDk; 
       NjwNt rpNyl;Lkkhk; ghz;L jhDk; 
jpupNjhlg; ghz;NlhL tpl ghz;lhFk;” 
                                                           Page no: 147 
 Vaatha paandu 
 Pitha paandu 
 Silethuma paandu 
 Thiridosa paandu 
 Visha paandu 
According to Agasthiyar‟ S view, 
“ghulh ghz;L tif nrhy;yf; Nfsha; 
Ghpthd ghz;lJ jhdQ; NrahFk; 
thuhlh tpthj gpj;jk; rPj ghz;L 
tifahd tplghz;L kpUj;jpfh ghz;” 
                        mfj;jpau; Fzthflk; 
                                                 Page No:6 
 Vatha paandu 
 Pitha paandu 
 Seedha paandu 
 Vida paandu 
 Miruthiga paandu 
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Yugi Chinthamani -800  
According to Yugi chinthamani -800 paandu noi is classified into 8 types. 
 Vatha paandu, Pitha paandu, Kaba paandu, Mukkutra paandu, Vida paandu, 
Mannun paandu, Eri paandu, nanju paandu. 
T.V. Sambasivam Pillai: 
According to T.V.Sambasivam pillai Paandu Noi is classified into 6 types.  
 Vatha paandu, Pitha paandu,  Kaba paandu,  Mukkutra paandu, Oodu paandu, 
and Neer paandu. 
Thanvanthri Vaithyam: 
According to „Thanvanthiri vaithyam‟ Paandu Noi is classified into 7 types. 
 Vatha paandu, Pitha paandu, Kaba paandu, Mukkutra paandu, Pitha Vatha 
paandu, Sannipatha paandu, and Paithiya paandu. 
Pararasa Sekaram: 
According to „Pararasa Sekaram‟ Paandu Noi is classified into 5 types, 
 Vatha paandu, Pitha paandu, Kaba paandu, Sanni paandu, Miruthika paandu. 
Jeeva Rakhsmirdham: 
According to „Jeeva Rakhsmirdham‟ Paandu Noi is classified into 7 types, 
 Vatha paandu, Pitha paandu, Kaba paandu, Thiridosa paandu, Nanju paandu, 
Miruthika paandu, Alimuga paandu. 
Vaidhiya sara Sangiraham: 
According to „Vaidhiya Sara Sangiraham‟ classified into 5 types, 
 Vatha paandu, Pitha paandu, Moola paandu, Moola pitha paandu, Visha 
paandu. 
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MURKURIKUNANGAL (PREMONITARY SYMPTOMS): 
czT Kjypa NtWghLfshy; jPf;Fw;wk; kpFe;J FUjpapd; epwj;ijAk; 
viliaAk; nfLj;J clw;F Ntz;ba Cl;lj;ijAk; nfhlhky; cliy 
ntSf;fr; nra;Ak;. gpd;G rpwpJ njhiyT elf;fpDk; fhy; Xa;e;J Nehjy;> 
ngU%r;R thq;fy>; cztpy; tpUg;gkpd;ik> tha;Fkl;ly>; jiyRw;wy;> fz; 
,Usy;> mbf;fb kaf;fkhjy;>; khh;G Jbj;jy;> cly; ,isj;jy; Mfpa 
FwpfisAk; fhl;Lk;. 
nghJ kUj;Jtk;. 
POTHU KURIGUNANGAL(GENERAL SIGN AND SYMPTOMS): 
“fdyJ nkj;jf; fhZk; 
fz;zJ ntSf;Fe; jhNd. 
ntSj;jpL KjL jhDk; 
ntbf;FNk jiyjjhd; NehFk; 
fidj;jpLQ; Nrhg khfpf; 
iffhyy;f srjp fhZk; 
gOj;jpLk; Kfk;Nt whFk; 
ghukha; grpna lhjhk; 
ghythflk; 
 Pallor present in conjunctivae, tongue, nail buds, 
 Headache 
 Anorexia 
 Fatigue/ weakness 
 Loss of appetite 
,e;Nehapy; cly; td;ik ehSf;F ehs; Fiwe;J elf;f ,ayhik> 
jiyNehjy;> khh;GJbj;jy>; fz; mbf;fb ,Usy;> jiyRw;wy>; kaf;fKz;lhjy;> 
%r;Rj; jLkhwy;> grpj;jP  nfly;> czT Ntz;lhik> cz;l rpW czTk; 
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the;jpahjy;> Mfpa Fwpfs; Njhd;Wk; ,d;Dk; kpfTk; ntSj;Jj; Njhy;RUq;fy;> 
cly; nkype;J gsgsgj;J ntSg;gjhy;> eff;fz;fs; jbj;J ntSj;jy;> eh 
ntbj;Jg; Gz;zhjy;> my;yJ ehtpd; Nky;Njhiy rPtpnaLj;jJ Nghd;W rpte;J 
fhZjy; my;yJ ehf;F gl;Lj;JzpNghy; tOtOj;J ntSj;Jf; fhzy; 
njhz;il fl;ly; vd;Dk; FwpfSk; fhZk;. 
- nghJ kUj;Jtk; 
 Loss of weight  
 Headache 
 Palpitation 
 Dimness of vision 
 Giddiness 
 Fatigue 
 Dyspnoea on excertion 
 Loss of appetite  
 Pallor in conjunctivae, skin, nail buds  
 Angular stomatitis  
“NghNk jhd; jPgdq;fs kl;Lg;gl;L  
nghypthd fz;tpopfs; nghpj;Jj; Njhd;Wk; 
MNk jhd; mrj;jpA khahrq; fz;L  
mth; eilAk; jsh;e;J ngU%r;R fz;L 
%Nkjhd; %u;r;ir Ald; khh;Jbj;J 
Kbthd fZf;fhy; tPf;fKz;lha;” 
                          -mfj;jpah; Fzthflk; 
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Agasthiyar Gunavagadam states that, dryness of the skin, pallor of the face, eyes, lips, 
tongue, and nails low volume pulse, anorexia, swelling of the eyelids, tiredness, 
dyspnoea on excertion, palpitation, oedema of the ankle joint, added heart sounds are 
mentioned as the signs and symptoms of Paandu Noi.  
According to Agasthiyar Vaidhiya Rathna Churukkam: 
    “cw;wNjhh; md;dNgjk; mNuhrf Kju ke;jk; 
  Kw;wpkhg;G Neha; %j;jpuk; nghd;dpd; td;ik 
  ntw;wpNrh; Gwq;fhy;if fzz; tPq;Fly; ntSj;jy; Nth;j;jy; 
  gw;wp njhf;fpw;fha; gapj;jpa ghz;LthNk” 
Page No: 61 
 Imperfectly cooking food  
 Anorexia 
 Dyspnoea – chest pain 
 Yellow coloured urine 
 Ankle oedema  
 Swelling of the eyelids 
 Pallor of skin 
 Sweating  
   The above said are the clinical manifestation of the Paandu Noi as per the details 
collected from Agasthiyar Rathina Churukkam. 
SYMPTOMS OF VARIOUS TYPES OF PAANDU NOI: 
Pitha Paandu: 
         “thnkd;w Nkdpnay;yhkQ;rspj;J 
kfhntSg;G cz;lhfp ke;jf;fz;zhe; 
jhnkd;w jhfnkhL %h;r;ir ahFe; 
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jdpthapy; kpsFNghw; whD iwf;Fk; 
 Nenkd;w neQ;RKs; jhD Kz;lha; 
neUf;fpNa %r;RKl; lJNt ahFq; 
   Nfhnkd;w fpWfpWj;J tha;ifg; ghFq; 
fpsu;gpj;j ghz;Lntdf; $wyhNk” 
                          -A+fpKdp     
 Yellowish discolouration of skin, diminished of the skin, thirst, fainting, tastes 
acrid like pepper, dyspnoea, bitter taste in mouth, are mentioned as the symptoms of 
Pitha Paandu by Yugi Muni.  
Mannun Paandu: 
,/J rpW Foe;ijfSk;> rpW tajpdUk;> fUTw;w ngz;fSk;> kz;> 
rhk;gy;> jpUePW> fw;G+uk;> ,tw;wpd; kPJ jdpj;j ,r;irnfhz;L msT fle;J 
cz;gjhy; fhZk; NehahFk;;. cl;nfhz;l nghUs;fSf;Nfw;g tapW Cjy;> 
nrhpahik> the;jp> fopr;ry;> Ruk;> tapw;Wg; GO Kjypa Neha;fs; fz;L cly; 
nkype;J> FUjp tw;wp>  ntSj;J> tPq;fp> khh;G Jbj;jy;> Kjypa 
FwpFzq;fisAk; fhl;Lk;. 
                 -rpj;j kUj;Jtk;. 
MUKKUTRA VERUPAADUGAL(PATHOLOGY): 
„Udal vanmai‟ is affected due to excessive intake of salts and sour foods, which 
cause indigestion and loss of appetite, due to this „Rasa‟, „Raktha thathus‟ are not well 
nourished. In addition to that „Ranjaga Pitham‟ is also disturbed which is responsible to 
gives redness to the blood leading to an increase in pitha kutram. Following this 
„Vaadha kutram‟ and „kabhab kuttram‟ too gets altered with the atraction of 
„paravugal‟. Futher „kabam‟ increases and producing generalized swelling of the body. 
        So this condition is due to increase in „Pitha kutram‟ which in due course, was 
supported by an increase in „Vaadha kutram‟ and „kabha kutram‟ with the alteration of  
paravugal. 
        According to Agasthiyar gunavagadam due to nutritional defect ie, Low iron diet 
leads to derangement in „Ranjaga pitham‟. Ranjaga pitham which is responsible for the 
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production of blood and it gives colour to the blood. So increase pitha humours leads to 
Paandu Noi. 
NAADI NADAI: 
Naadi is omni present cosmic vibrant, vital force connecting the macrocosmic with the 
humanbody is a subtle diagnostic tool handled by the siddhars from the unknown past. 
These vibrations enter the human body from the universe, keep the life vibrant 
continuously and aquire the energy required for human metabolism. The examination 
of Naadi has been recognized as one of the principal means of diagnosis and progonosis 
of the disease from time immemorial. Any change in their dhoshas is best diagnosed by 
feeling the naadi, the power of the Naadi manifest in the body as their vital forces 
namely vadha, pitha and kabha, the three uyir thathukal which regularize   and integrate 
the life activity in each and every living being. 
         Increase or decrease in mathirai level of Vaatham, pitham, kabam are felt using 
the fingers  
 Index fingers for vaatham 
 Middle fingers for pitham  
 Ring fingers for kabam 
Naadi nadai in Paandu noi: 
Pitha naadi, kabha naadi, vatha kabha naadi, kabha vatha naadi,kabha pitha naadi 
may present.  The quotations from sadhaka naadi nool and valmeegiyar vaithyam 
confirm this fact. 
   “rpwg;ghd gpj;jjpy; thj ehb 
      NrhpY}wjhJ el;lKju gPil 
            Ciwg;ghfr; nrhpahik Fd;kQ;#iy 
      Aw;w Ruq;fpuhzp tapw;wpiur;ry; ke;jk; 
  miwg;ghd xq;fhu GwePh;Nfhit 
      Mahr kpuf;fnkhL kaf;f %h;r;ir 
  Kiwf;fha;T tp\tPf;fk; %y tha;T 
      Kulhd Neha;gyT KLFk; gz;Ng” -  
                                                   Page no: 184    
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“jhdKs;s Nrj;Jke;jh dpsfpy; ntg;G. 
     rakPis ,Uky;ke; jhu fhrk; 
<DKWQ; …………………………… 
……………………………………… 
VdKWq; fhkhiy ghz;L Nrhig 
      VORuq;fs; gyJf;fk; tplKz;lhNk” 
         Page No:179        
   “fz;lhNah rpNyw;gdj;jpy; thj ehb 
fye;jpL ……………................. 
……………………………………………  
tpz;lhNy ,isg;gpUky; Nrhig ghz;L 
…………………………………………. 
                          page no: 184 
                   “,lkhdNrj;Jkj;jpy; gpj;j ehb 
vOe;jDfpy; tplKlNd tPf;fKz;lhk; 
jplkhd Fsph;fha;r;ry; kQ;rs; NehTe; 
  Njfj;jpYisr;rypisg; gpUky; the;jp 
tplkhd neQ;rilg;G Rthrk; tpf;fy; 
ntFRuKk; ehtwl;rp ghz;L Nuhfk; 
mlkhd Ftisuj;j kjprhue;jhd; 
mZfpntF gyNeha;f;F jlq;fz;lhNah” 
Page No: 187 
Valmigiyar Vaithiyam: 
                   “Fjpj;jpLk; thjehb $bLk; gpj;jj;NjhNl 
jj;jpNa elf;Fkhfpy; rhPuNk nkj;Jtj;jp 
nkj;jNt tha;ePUwp NkdpNa ntSj;Jf; fhZk;   
gpj;jghz;L Nuhfnkd;W Ngrpdhu; #jhaj;jhNd” 
thy;kPfpah; tj;jpak; 
Page No: 34 
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Asathiya Kurigunagal: 
 If diarrhea persists in “Paandu Noi” the prognosis is said to be bad as given in 
„kannusamiiyam‟ and also in  „Sathaga naadi‟ 
       “ghz;L gpuNkfk; gd;thj #isFd;kk; 
    Ntz;lh raQ;rd;dp ntz;Nrhig ePz;l 
    mjpePNu fhkhiy ahddgpzp jk;K 
    sjp rhukh fhjwp.” 
                        -fz;Zrhkpak; 
“jhdhd gpuNkfk; thj #iy 
rhh;thd ePuopT Fd;k Nuhfk; 
khdhd raNuhfQ; rd;dp Njhlk; 
mLj;jtplq; fhkhiy ghz;L Nrhif 
khNdNfs; fgNuhf ke;jpu tpahjp 
kQ;rs;Neha; FiyNehT gapj;jpa Nuhfk; 
CdhFk; tUkplj;jpy; mjprh uq;fs; 
cz;lhfpy; mrhj;jpakh KWjp jhNd” 
                             -rjf ehb     
     ntSg;G Nehapy; mjprhuk; te;jhy; ,e;Neha; jPuhJ. 
    ntSg;G Nehapy; the;jp> fopr;ry;> tPPf;fk;> ePh;Ntl;il> tpf;fy;> Mfpa 
FwpFzq;fspy; xd;W my;yJ gy me;Neha;fspy; Jiz Nehahfpj; Jd;gq;fis 
mjpfkhf tpistpf;fpd; vspjpy; jPuhJ. 
                                         -rpj;j kUj;Jtk;. 
PINIYARI MURAIMAI (DIAGNOSIS): 
Piniyarimuraimai is the method of diagnosing disease affecting the man. It is based 
upon three main principals. They are  
1. Porial arithal (Inspection of as the five senses of perception namely Skin, 
Tongue, Eyes, Nose, and Ear) 
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2. Pulanal arithal (Palpation of five objects of senses, which are tactile 
sensation, Taste, Sight, Smell, and Sound) 
3. Vinathal (Interrogation) 
FINDING WITH RESPECT TO PAANDU NOI: 
Pori, Pulanal Arithal: 
MEI: 
 Pallor of skin 
 Mild Yellowish discolouration of skin, the characteristic feature of all pitha 
disease. 
 Koilonychias 
VAI: 
 Pallor of tongue 
 Glossitis 
 Angular stomatitis 
 Atropy of papillae(Bald tongue) 
KAN: 
 Pallor of conjunctivae 
VINATHAL: 
 Anorexia 
 Breathlessness / Dyspnoea 
 Dimness of vision 
 Thirst 
 Palpitation 
 Faintness 
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 Giddiness 
 Lack of concentration 
 Lack of memory 
ENVAGAI THERVUGAL: 
Envagai Thervukal is a unique method of diagnosing the disease, which was developed 
by Siddhars.  
“ehbg; ghprk; ehepwk; nkhoptpop 
kyk; %j;jpukpit kUj;JuhAjk;.” 
“nka;f;Fwp epwe;njhsp tpopeh tpUkyk; iff;Fwp” 
                   -Neha; ehly; Neha; Kjy; ehly;. 
1. Naa 
2. Niram 
3. Mozhi 
4. Vizhi 
5. Malam 
6. Moothiram 
7. Sparisam 
8. Naadi 
PAANDU IN RELATION WITH ENVAGAI THERVUGAL: 
 Naa (Tongue): pallor of tongue, loss of taste buds, glossitis, stomatitis,  
atropy of papillae are seen. 
 Niram (colour): whether the natural colour becomes pale / dimished. 
 Mozhi (sound): This include clarity of speech, any disturbances, high or 
low pitched voice, slurring and incoherent speech and horseness of voice. 
 Vizhi (Eyes): pallor of conjunctivae, dimness of vision is seen 
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 Sparisam (palpation): The warmth, chillness, dryness, roughness of the 
skin, sweating, tenderness, ulcer, and hepatomegaly may be noted. 
 Maalam (Faeces): Constipation / diarrhea may be noted. 
 Moothiram (Urine): At times oliguria 
NEER ILLAKKANAM (Method of collection of urine): 
“mUe;J khwpujKk; mtpNuhjKkjha; 
mlfy; myh;jy; mfhyT+d; jtph;e;joew; 
Fw;wstUe;jp cwq;fp itfiw 
Mbf;fyrj; jhtpNa fhJ nga; 
njhUK$h;j;jf; fiyf;Fl; gLePhpd; 
epwf;Fwp nea;f;Fwp epUgpj;jy; flNd” 
                       -Njuh; ePh;f;Fwp nea;f;Fwp E}y;. 
                    Page no: 265 
After waking up in the morning, the first voided urine is collected in a wide 
mouthed glass container and is subjected to the analysis within one and half hours. 
NEER KURI: 
    “te;j ePh;f;fupnail kzk; Eiu vQ;rnyd;” 
                          -rpj;jkUj;Jthq;fRUf;fk;. 
Urine has the following characters, 
Niram    - colour   
Edai      - weight 
Manam – odour 
Nurai    - froth 
Enjal  -  sediments /quality. 
 These factors play a major role in diagnosing a disease. 
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NEIKURI: 
  “epwf;Fwpf; Fiuj;j epUkhd ePupw; 
 rpwf;f ntz;nza;Nau; rpWJsp eLtpj; 
 njd;Dwj; jpwe;njhyp Nahfjikj;jjp 
 dpd;wjptiy Nghk; newptpopawpTk; 
 nrd;Wj GfYQ; nra;jpia GzNu” 
                     -Njuh; ePh;f;Fwp nea;f;Fwp E}y;. 
                                                  Page no: 279. 
       The specimen collected for neikuri is kept open in a glass dish being exposed well 
to the sunlight. Add one drop of gingily oil without shaking. It should not be disturbed 
from its position and spreading of the oil drop should be noted. 
“muntd ePz;bd/Nj thjk;” 
  “MopNghw; gutpd; m/Nj gpj;jk;” 
  “Kj;njhj;J epw;fpd; njhopt njd; fgNk” 
 Vadha neer -      oil drop spread out like a snake.            
 Pitha neer  -       oil drop resemble the shape of ring  on spreading 
 Kabha neer -     oil remain and floating like a pearl   
NEIKURI IN PAANDU NOI: 
The sample collected for observing Neikuri from patients with paandu noi, 
showed a ring shaped structure. Because the prime cause ofbthe disease is the increase 
in pitha kutram. 
UYIR THATHUGAL: 
Three vital forces are necessary in proper ratio for the normal functioning of the 
body. They are, 
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o Vatham 
o Pitham 
o Kabham 
Each one of it has got its own characters and function in the body. 
VATHAM: 
Ten form of vatham in paandu noi: 
1. Piranan (Uyirkaal)  – Affecteddue to breathlessness  
      dyspnoea. 
2. Abhanan (kizhnokkumkaal)  – Affected in case of constipation 
3. Viyanan (paravukaal)  – Affected because of pallor of the skin. 
4. Udhanan(Melnokkukaal) – Generally not affected  
5. Samanan(Nadukkaal)   – Affected because of anorexia 
6. Naagan    – Generally not affected 
7. Koorman    - Affected because of dullness of vision. 
8. Kirukaran    –Affected in case of anorexia. 
9. Devadhathan   – Affected in case of sluggishness and  
     insomnia 
10. Dhananjeyan   –Not appliable 
PITHAM: 
Five form of pitham, in Paandu Noi 
1. Anal pitham (paasagam)        – Affected because of loss of appetite. 
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2. Ranjagam (vannapitham) –Affected because of haemoglobin                 
concentration is altered                       
3. Prasagam (Olithee)  – Affected because of pallor of skin. 
4. Sathagam (Atralanal)  – Affected because of inability to do the  
     works properly and sluggishness. 
5. Aalosagam (Nokkazhal)  – Affected because of dimness of vision. 
KABAM: 
Five form of kabam, in paandu noi 
1. Avalabagam – Affected because of dyspnoea. 
2. Kilaethagam – Affected because of anorexia 
3. Pothagam  – Generally not affected 
4. Tharpagam – Generally not affected 
5. Santhigam – Generally not affected 
UDAL KATTUGAL: 
1. Saaram 
2. Senneer 
3. Oon 
4. Kozhuppu 
5. Enbu 
6. Moolai 
7. Sukkilam / suronitham. 
These are the seven udal kattugal building elements of the human body whose 
normal function is essential for our well being. Any deviation of this thathus will lead 
to pathological conditions. 
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CHARACTERS: 
Saaram: 
 Separated from food. Nourishes the body. 
Senneer: 
 It is responsible for the existence of knowledge, strength, glory and blood 
components.     
Oon: 
Moulding the shape of the body and muscles.   
Kozhuppu: 
 Acts as lubrication for the fumctioning of organs and provide a cover for the 
body. 
Enbu: 
 Structural unit of the body – Responsible for the shape of the body. 
Moolai: 
 It represent the bone marrow and it strengthens the bone. 
Sukkilam/ Suronitham: 
 Responsible for the propagation of species. 
Affected Thathus In Paandu Noi: 
Saaram: 
 Affected because of anorexia and indigestion 
Senneer 
 Affected because of pallor of skin and conjunctiva 
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PARAVUKAALAM (SEASON): 
 The whole year is constituted by six seasons, which will modify the physiology 
and make them susceptible to certain specific diseases which are common in that 
season. 
Physiologically the types of alteration of mukkutram are, 
Paruvakaalam 
Thannilai 
Valarchi 
Vetrunilai 
Valarchi 
Thannilai 
Adaithal 
Kaar kalam  
(Aavani & purataasi) 
Pitham Vaatham 
- 
Koothir kaalam 
(Aippasi & kaarthigai) 
- Pitham Vaatham 
Munpani kaalam 
(Maargazhi & Thai) 
- - Pitham 
Pinpani kaalam 
(Masi & panguni) 
Kabam   
Illavenil kaalam 
(Chithirai & Vaigasi) 
 Kabam  
Mudhuvenil kaalam 
(Aani & Aadi ) 
Vatham  Kabam 
 
THINAI (LAND): 
Siddhars classified the lands into five types. They are 
1. Kurinji  -  Mountain range 
2. Mullai - Pastoral area of the forest 
3. Marutham – The fertile river bed 
4. Neithal  – The coastal region 
5. Paalai   -  Arid desert. 
 The winter season gives good health to the man, early summer and latter rainy gives 
moderate health. Whereas early rainy and latter summer are more prone to diseases, 
that‟s why Siddhars called it as Aanaga kaalam. 
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 Marutham nilam is the fertile area where no disease occur.   
 People living in Kurinji, Mullai, Neithal and Paalai may have increased chance 
to acquire paandu noi.        
THODAR NOI OF PAANDU NOI(COMPLICATION): 
According to Agasthiyar Vatha Naadi, 
tpsk;gNt ghz;L Kw;wpUf;Fk; NghJ 
kPwpNa gpj;jt];Jjidg;………………… 
G+z;bLNk fhkhiy naDk; Nuhfk;” 
                                               Page no: 269 
       When the disease progresses kabam increases resulting in sobai (oedema), and 
when Paandu Noi is severe excessive intake of pitha diets leads to kaamaalai 
(jaundice). 
In Sarabendra Vaidhi Muraigal: 
               According to siddha system of medicine as per Yoogimuni chronic Anaemia 
associated with following disease like  
LINE OF TREATMENT FOR PAANDU NOI: 
The speciality of siddha treatment emphasise not only for complete healings but also 
for the prevention and rejuvenation. This is said as follows, 
 Kaappu(Prevention) 
 Neekkam(Treatment) 
 Niraivu(Restoration) 
 When treating for cure of the disease the following principle s must be noted. 
 “Neha;ehb Neha;Kjy; ehbaJ mJjzpf;Fk; 
  tha;ehb tha;g;r; nray;”                                    -jpUf;Fws; 
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 To diagnose the disease and to find out the root cause of the disease and then to 
make the plan about curing the disease will provide good treatment. 
 Our siddha system of medicine is focused more on food habits and lifestyles on 
treatment. The change in food habits paves way for the derangement of „Thirithodam‟, 
which is the root cause for several aliments. 
 The normal mathirai level of vaadha, pitha, kabha kutram are 1:1/2:1/4. The 
principle reason for variation in this level is food changes. 
 The aim of the treatment of treatment in Paandu Noi (Iron Deficiency Anaemia) 
most of the children are affected by worms (any ova) infestation so antihelminthic drug 
are used first.                           
 All the cases are affected by loss of appetite. So best appetizers are used to give. 
 Treatment is given not only to cure the disease but for its prevention and 
rejuvenation. Especially in Paandu Noi, Rasam, Ratha thathus are mostly affected. So 
Iron components are used in the trial drug. Also food rich in iron is recommended. 
TRIAL DRUG: 
 The author took Chitramutti Nei as a trial drug for Paandu Noi 
Dose: 4 – 5 ml, twice a day, after food 
 
DIET: 
 “kUe;Nj czT czNt kUe;J 
 khWghby;yhj Tz;b kWe; Jz;zpd; 
 CWgh by;iy Aaph;f;F.” 
                Dietetics is of great importance in Siddha system especially in Paandu Noi 
diet is main factor for good prognosis. As over in take of consuming unbalanced and 
incomparable diet is considered to be the prime causative for upsetting the three dosha 
balance leading to manifestation of various aliments. 
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 Easily digestable food with iron content is preferred. 
a. Karisalai, Ponnanganni, Sirukeerai, Arukeerai, Manathakkali, Murungai 
keerai. 
b. Katharipiinju, Avarai pinju, Murungai pinju, Vazhaikattchal. 
 In the earlier stage of the disease food substances that are capable of stimulating 
the appetite and improving haemoglobin content of blood are given. 
 In severe case with anorexia and indigestion only kanji and soups are advised. 
 To improve general health Kaadai, Gowthari, Udambu, Vellattukari, are 
included in  the diet 
 Regular consumption of dates are encouraged  
 Wheat, Green leafy vegetables, and oats are rich in iron. 
 Fruits, which are rich in iron like Orange, Apple, Grapes,  
Pomegranate, Fig, Goosebery, Banana were encouraged.   
 Ragi, Panai Vellam, Kadalai, Ellu can be given. 
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MODERN ASPECT 
 The commonest nutritional deficiency disorder present throughout the world is 
iron deficiency anaemia. 
 Blood is a connective tissue in fluid form. It is considered as the fluid of life, 
because it carries oxygen from lungs to all parts of the body and carbon dioxide from 
all parts of body to the lungs.It is known as the fluid of growth because it carries 
nutritive substances from the digestive system and hormones from endocrine gland to 
all the tissues.The blood is also called the fluid of health because it protects the body 
against the diseases. 
Blood contains iron in the form of haemoglobin and as cytochromes etc. Any 
form of iron deficiency cause anaemia. 
PROPERTIES OF BLOOD: 
Color     :        Blood is red in color.   
                         Arterial blood is scarlet red 
venous blood is purple red. 
Volume : Average volume of blood 
- 5litre  [in normal adults]. 
  -450ml [in new born baby]. 
  -4.5ml [in female]. 
pH:                 7.4 
Specific gravity: 
  Total blood    -1.052 – 1.061 
  Blood cells    -1.092 – 1.101 
  Plasma          -1.022 – 1.026  
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Viscosity: 
Five times more viscous than water due to red blood cell and plasma proteins. 
COMPOSITION OF BLOOD: 
Blood consists of a solid protein 45% and a fluid protein 55% 
 Solid protein constitutes RBC,WBC and platelets 
 Fluid portion is plasma 
BLOOD CELLS: 
Blood cells are of three types  
1. Red blood cells or erythrocytes 
2. White blood cells or leucocytes 
3. Platelets or thrombocytes 
Red blood cells or Erythrocytes: 
The major function of red blood cells, also known as erythrocytes. The red color of the 
red blood cells is due to presence of the coloring pigment called haemoglobin. RBC 
plays a vital role in transport of respiratory gases.  
  The RBC count     - 4 to 5.5 million per cubic mm of blood. 
 In adult males - 5million /cu.mm 
 In adult females - 4.5 million /cu.mm 
MORPHOLOGY OF RED BLOOD CELLS: 
Normal Shape   : Disc Shaped And Biconcave ( Dumb-Bell Shaped). 
Normal Size       : 7.2µ (6.9 – 7.4µ) In Diameter. 
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Thickness            : Periphery-2.2µ (Thicker) 
         Centrally-1 µ (Thinner) 
Surface Area       : 120sq.µ 
Volume                : 90 -95cu. µ 
ERYTHROPOIESIS:- 
Erythropoiesis is the process which involve the origin, development and maturation of 
erythrocytes. 
Sites of Erythropoiesis:- 
 First two months of intrauterine life - mesenchyme of yolk sack. 
 From three months of intrauterine life- Liver, Spleen, Lymphoid organ. 
 Last three months of intrauterine life- Red bone marrow and Liver. 
 In new born babies, growing children, and adults RBCs are produced only in 
red bone marrow. 
 Upto the age of 5to 6 years - Red bone marrow of all the bones. 
 From the age of 6 to 20years- Red bone marrow of all the long bones and flat 
bones. 
Process of erythropoiesis:-  
Stem cells: 
The stem cells are the primitive cells in the bone marrow, which give rise to all 
the blood cells. Stem cells are defined as a cell which is capable of both self-renewal 
and differentiation. 
Pluripotent haemopoietic stem cells (PHSC) are derived from stem cells. PHSC 
are defined cells that can give rise to cells of all groups of haemopoietic cells like 
myeloid cells and lymphoid cells. 
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In the early stages, the PHSC are not designates to form a particular type of 
blood cell, and it is also not possible to determine the blood cell to be developed from 
these cells , hence the name uncommitted PHSC. 
In adults only a few number of these cells are present. Best source of the cells is 
the umbilical cord blood. 
When the cells are designated to form a particular type of blood cells the 
uncommitted PHSCs are called committed PHSCs. 
Committed PHSCs are of two types. 
1. Lymphoid stem cells (LSC)- which gives rise to Lymphocytes and natural 
killer (NK cells) 
2. Colony forming blastocytes- Which gives rise to myeloid cells. 
Myeloid cells are the blood cells other than lymphocytes. 
When grown in cultures these cells form colonies hence the name colony forming 
blastocytes.  
The different units of colony forming cells are: 
 Colony forming unit – Erythrocytes(CFE-E) 
              Cells of this unit develop into erythrocytes. 
 Colony forming unit granulocytes –Monocytes (FU-GM) 
     These cells give rise to granulocytes (Neutrophils, Basophils and Eosinophils and 
Monocytes) 
 Colony forming unit- Megakaryocytes(CFU-M),  
                           Platelets are formed from these cells 
Changes during Erythropoiesis: 
Cells of CFU-E pass through different stages finally become matured RBCs. 
During these changes four important changes are noticed  
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 Reduction in size of the cells 
 Disappearance of nucleoli and nucleus 
 Appearance of haemoglobin 
 Changes in the staining properties of the protoplasm. 
STAGES OF ERYTHROPOIESIS: 
Various stages between CFU-E cells and matured RBCs are 
1. Proerythrolast 
2. EarlyErythroblast 
3. Intermediate Erythroblast 
4. Late Normoblast 
5. Reticulocyte 
6. Mature Erythrocyte 
 
 
 
 
 
 
  
34 
 
 
 
FACTORS NECESSARY FOR ERYTHROPOIESIS:-  
 General factors 
 Maturation factors 
 Factors necessary for haemoglobin formation 
General factors 
 General factors necessary for erythropoiesis are  
1. Erythropoietin  
2. Thyroxine 
3. Hemopoietic growth factor 
4. Vitamins-B, C, D and E 
Maturation factors 
1. Vitamin B12(Cyanocobalamin) 
2. Intrinsic factor of castle 
3. Folic acid 
Vitamin B12 (Cyanocobalamin) 
Vitamin B12 is called extrinsic factor because it is obtained mostly from diet. Vitamin 
B12is stored mostly in the liver and in small quantity in muscle.When necessary, it is 
transported to the bone marrow to promote maturation of RBCs. 
Intrinsic factor of castle 
The extrinsic and intrinsic factors are together called haematinic principle. 
Folic acid 
It is also essential for maturation. It is required for the synthesis of DNA. In the 
absence of folic acid the synthesis of DNA decreases causing failure of maturation.This 
leads to anaemia  
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Factors necessary for Haemoglobin formation: 
Various materials are essential for the formation of haemoglobin in the RBCs. 
Such factors are,  
1. First class protein and aminoacids 
2. Iron: 
  -It is necessary for the formation of heme part of the haemoglobin  
3. Copper: 
-It is necessary for the absorption of iron from the gastrointestinal tract. 
4. Cobalt and nickel: 
-It is essential for the utilization of iron during haemoglobin formation. 
5. Vitamins: 
-Vitamin C, Riboflavin, nicotinic acid and pyridoxine is also essential for the 
formation of haemoglobin. 
LIFE SPAN AND RATE OF RBC:- 
Average life span of red blood cells is about 120 days.The senile red blood cells 
are destroyed in reticulo-endothelial system. 
When the cells become older the cell membrane becomes more and more 
fragile. So these cells are destroyed while trying to squeeze through the capillaries. The 
destruction occurs mostly in the capillaries of the spleen because the splenic capillaries 
have a thin lumen. So the spleen is usually called „Grave yard‟ of red blood cells. 
Daily 10 % of RBCs, which are senile, are destroyed in normal young healthy 
adults. It causes release of about 0.6g% of haemoglobin into plasma. 
HAEMOGLOBIN 
Haemoglobin is the coloring matter of RBC. The molecular weight of 
haemoglobin is 68,000. 
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STRUCTURE OF HAEMOGLOBIN  
Haemoglobin is a conjugated protein. It consists of a protein combined with an iron 
containing pigment in heme. 
 Heme also forms a part of structure of myoglobin (oxygen binding pigment in 
muscles) 
 Neuroglobin(Oxygen binding pigment in brain) 
STRUCTURE OF HAEMOGLOBIN 
 
 
 
 
 
 
 
Iron : 
Normally it is present in ferrous form Fe
++
. It is in unstable or loose form. 
Porphyrin :- 
The pigment part is called porphyrin. It is formed by four pyrole ring called I, 
II, III, IV. The Pyrole rings are attached to one another by methane (CH4) bridge 
The iron is attached to  
-N of the each pyrole ring and  
-N of the globin molecule 
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Globin 
This contains four polypeptide chains 
α chains-2 
β chains -2 
Types of haemoglobin 
Haemoglobin is of two types 
1. Adult haemoglobin- HbA 
2. Fetal haemoglobin- HbF 
There are structural differences between the two types of haemoglobin. In adult 
haemoglobin, the globin contains two α chains and two β chains. In fetal haemoglobin, 
there are two α chains and two γ chains instead of β chains. 
METABOLISM OF HAEMOGLOBIN: 
Synthesis of haemoglobin: 
         Synthesis of haemoglobin actually starts in proerythroblastic stage. The 
production of the haemoglobin is continued unit/stage of reticulocyte. The heme 
portion of haemoglobin is synthesized in mitochondria from acetic acid and glycine. 
2 succinyl CoA + 2glycine  4 pyrrole 
 
4 Pyrrole  Protoporphyrin IX 
 
Protoporphyrin + Fe
++ Haeme 
 
                             Haeme + Polypeptide  Haemoglobin chain(α or β) 
2α –chains + 2β chainsHaemoglobin A 
 
The protein part of globin is synthesized in ribosomes. 
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Destruction of Haemoglobin:- 
 After the life span of 120 days, the RBS is destroyed in the reticuloendothelial 
system particularly in spleen and the haemoglobin is released into plasma. 
Soon the haemoglobin is degraded in the reticuloendothelial cells and split 
into globin, iron and porphyrin. 
 Globin is utilized for the resynthesis of haemoglobin. Iron is stored in the body 
as ferritin and haemosiridin which are reutilized for the synthesis of new 
haemoglobin. 
 Porphyrin is converted into a green pigment called biliverdin. In human being 
most of the biliverin is converted into a yellow pigment called bilirubin. 
NORMAL VALUES OF HAEMOGLOBIN OF DIFFERENT AGE GROUP 
Age group Mean(G/dl) Range (G/dl) 
Cord blood  17.1 13.7 – 20.5 
7 days 18.8 14.6-23.0 
20 days  15.9 11.3- 20.5 
45 days 12.7 9.5- 15.9 
75 days 11.4 9.6-13.2 
120 days 11.9 9.9-13.9 
1 year 12.2 10-13.0 
5 year 12.5 12-13 
10 year 13.5 13-14 
Older 15 14-15 
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PACKED CELL VOLUME AND BLOOD INDICES. 
Packed cell volume (PCV) is the haematocrit value expressed as the percentage 
of cellular elements with that of whole blood. 
BLOOD INDICES: 
Blood indices are specifically meant for erythrocytes. Blood indices have got 
diagnostic value in determining the type of anaemia. 
DIFFERENT BLOOD INDICES: 
Following are the different blood indices  
1.  Mean Corpuscular Volume (MCV) 
Mean Corpuscular Volume is the average volume of single red blood cells and 
it is expressed in cubic microns(cu.µ) 
MCV=
𝑷𝑪𝑽𝒊𝒏 𝟏𝟎𝟎𝟎𝒎𝒍𝒐𝒓 𝟏𝟎𝟎𝒎𝒍×𝟏𝟎 
𝑹𝑩𝑪𝒄𝒐𝒖𝒏𝒕𝒊𝒏𝒎𝒊𝒍𝒍𝒊𝒐𝒏𝒔𝒑𝒆𝒓𝒄𝒖 .𝒎𝒎
 
2. Mean Corpuscular Haemoglobin  (MCH) 
Mean Corpuscular Haemoglobin is the quantity or amount of haemoglobin 
present in one red blood cell. It is expressed in micrograms or pictograms(pg) 
MCH = 
𝑯𝒂𝒆𝒎𝒐𝒈𝒍𝒐𝒃𝒊𝒏𝒊𝒏𝒈𝒓𝒂𝒎𝒔𝒑𝒆𝒓 𝟏𝟎𝟎𝟎𝒎𝒍𝒐𝒇𝒃𝒍𝒐𝒐𝒅×𝟏𝟎𝟎×𝟏𝟎
𝑹𝑩𝑪𝒄𝒐𝒖𝒏𝒕𝒊𝒏𝒎𝒊𝒍𝒍𝒊𝒐𝒏𝒔𝒑𝒆𝒓𝒄𝒖 .𝒎𝒎
 
3. Mean Corpuscular Haemoglobin  Concentration (MCHC) 
It is the amount of haemoglobin expressed in relation to volume of one blood 
cell. So the unit of expression is percentage. 
MCHC = 
𝑯𝒂𝒆𝒎𝒐𝒈𝒍𝒐𝒃𝒊𝒏𝒊𝒏𝒈𝒓𝒂𝒎𝒔𝒑𝒆𝒓 𝟏𝟎𝟎𝒎𝒍𝒐𝒇𝒃𝒍𝒐𝒐𝒅×𝟏𝟎
𝑷𝑪𝑽𝒊𝒏 𝟏𝟎𝟎𝒎𝒍𝒐𝒇𝒃𝒍𝒐𝒐𝒅
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4.  Colour Index: 
This is the ratio between the percentage of the haemoglobin and the percentage 
of red blood cells in the blood. 
CI = 
𝑯𝒂𝒆𝒎𝒐𝒈𝒍𝒐𝒃𝒊𝒏%
𝑹𝑩𝑪%
 
All the above mentioned blood indices are reduced in iron deficiency 
anaemia. 
NORMAL VALUES: 
  Packed Cell Volume (PCV): 
3 month – 10 years                    – 36.0±5.0% 
11 – 15 years                             – 39.0 ± 5.0% 
Mean Corpuscular Volume (MCV) 
3 months -10 years                   -80 cu.µ 
11-15 years                              – 82 cu.µ 
Mean Corpuscular Haemoglobin  (MCH) 
3months – 10years                   -27 picograms  
11- 15 years                           – 28 picograms 
Mean Corpuscular Haemoglobin  Concentration (MCHC) 
3months to 10 years               - 34g/dl 
11- 15 years                          - 34g/dl 
Reticulocytes: 
6 months – 6 years                -1.0% 
7- 12 years                           -1.0% 
41 
 
 
 
IRON : 
Iron is one of the most essential trace elements in the body. Heme is the most 
predominant iron containing substance. Iron is important for the formation of 
haemoglobin, myoglobin, cytochromes and other components of respiratory enzymes 
like cytochrome oxides, catalase and peroxidase. 
NORMAL VALUE AND DISTRIBUTION OF IRON IN THE BODY: 
The total quantity of iron in the body is about 4 grams. The approximate 
distribution of iron in the body is as follows: 
In the haemoglobin – 65 - 68% 
In the muscle as myoglobin –4% 
As intracellular oxidative heme compound – 1% 
In the plasma as transferrin – 1% 
Stored in the reticuloendothelial system – 25 – 30% 
BIOCHEMICAL FUNCTION: 
1. Haemoglobin and myoglobin are required for the transport of O2and CO2. 
2. Cytochromes and certain non heme proteins are necessary for electron transport 
chain and oxidative phosphorylation. 
3. Peroxidase, the lysosomal enzyme, is required for phagocytosis and killing of 
bacteria by neutrophils. 
4. Iron is associated with effective immunocompetence of the body. 
Daily iron requirement in different age group. 
Males 11 years to 17 years            - 12mg/day. 
Upto 10 years male and female       - 10mg/day. 
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DIETARY IRON: 
The dietary iron comes from two sourses, heme and non heme, the latter being 
the major source of iron in diet and is found in varying degrees in all foods of plant 
origin. 
 Heme iron is present in meet fish and poultry, but the intake of these product is 
generally low. Heme iron is better absorbed than non heme iron and is not influenced 
by dietary factors. 
 Breast milk even in spite of low levels of iron (0.5mg/lit) has a better absorption 
and bioavailability as compared to cow‟s milk. Good source of iron in diet include 
pulses, dhals, green leafy vegetables, dates, nuts, jaggery, meat and fish. Poor sources 
of iron in the diet include milk, wheat, polished rice. Administration of 50mg of 
vitamin C increases iron absorption by two folds. 
FACTORS AFFECTING IRON ABSORPTION: 
1. Acidity, ascorbic acid and cysteine promote iron absorption. 
2. In iron deficiency anaemia, iron absorption is increased to 2- 10 times that of 
normal. 
3. Small peptides and amino acids favour iron uptake 
4. Phytates found in cereals and oxalates found in leafy vegetables interfere with 
iron absorption. 
5. A diet with high phosphate content decreases iron absorption while too low 
phosphate promotes. 
6. Impaired absorption of iron is absorbed in malabsorption syndrome such as 
steatorrhoea. 
7. In patients with partial or total surgical removal of stomatch and or intestine, 
iron absorption is severely impaired. 
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IRON METABOLISM: 
Absorption : 
 Iron is mainly absorbed in the stomach and duodenum. Iron is mostly found in 
foods in ferric form. Fe
3+
 bound to proteins or organic acids. In the acid medium 
provided by gastric hydrochloric acid the Fe
3+
is released from foods. Reducing 
substances such as ascorbic acid (vitamin c) and cysteine convert ferric iron (Fe
3+
) to 
ferrous form Fe
2+
.Iron in ferrous form is soluble and readily absorbed. 
Iron in  the mucosal cells: 
 The iron Fe
2+
entering the mucosal cells by absorption is oxidized to ferric (Fe
3+
) 
form by the enzyme ferroxidase. 
 Fe
3+ 
then combine with apoferritin to form ferritin which is the temporary 
storage form of iron and is present in gastrointestinal mucosa, bone marrow, liver and 
spleen. From the mucosal cells, iron may enter the blood stream. 
TRANSPORT OF IRON IN THE PLASMA: 
The iron liberated from the ferritin of mucosal cells enters the plasma in ferrous state, it 
is plasma in ferrous state, it is plasma in ferrous state, it is oxidized to ferric form by a 
copper containing protein, ceruloplasmin. Another cuproprotein ferroxidase II also help 
for the conversion of Fe
2+
to Fe
3+
. 
 Ferric iron that binds with a specific iron binding proteins namely transferrin or 
siderophilin. 
           Each transferrin molecule can bind with two atoms of ferric ion Fe
3+
. The 
plasma transferrin can bind with 400mg of iron /dl plasma. This plasma is known as 
total iron binding capacity(TIBC) of plasma. 
     Hemosiderin is another iron storage protein, accumlate in the spleen and liver when 
the supply of iron is in excess of body demands. 
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IRON IS A ONE WAY SUBSTANCE 
          Iron is very efficiently utilized and reutilized by the body. Further, iron losses 
from the body are minimal which may occur through bile, sweat, hair loss etc. Iron is 
not excreted in urine. 
ANAEMIA 
DEFINITIONS: 
 Anaemia is present when the haemoglobin level in the blood is two standard 
deviations below the mean for the particular age and sex. 
 Physiological definition of anaemia is a condition in which tissue hypoxia 
occurs due to inadequate oxygen carrying capacity of blood. 
 WHO criteria for diagnosis of anaemia. 
Children of 6 months- 6years <11 
Children of 6 years -14 years <12 
Grading of Anaemia : 
WHO grades anaemia according to haemoglobin level as follows. 
 Hb between 10gram and cut off point for age      -Mild  
 Hb between 7-10gram                                       –Moderate  
 Hb under 7gram                                                –severe 
CLASSIFICATION:  
A. Based on the Morphology 
Based on the red cell size haemoglobin content and red cell indices anaemia are 
classified as follows. 
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1. Microccytic hypochromic anaemia 
2. Normocytic normochromic anaemia 
3. Macrocytic normocytic anaemia 
4. Macrocytic hypochromic anaemia 
B .Based on Etiopathogenesis 
1. Nutritional anaemia  
2. Haemolytic anaemia  
3. Haemorrage  
4. Bone marrow suppression  
5. Infections  
6. Miscellaneous 
I.  Disorders of impared RBC production  
a. Deficiency anemia  
I. Iron deficiency anaemia  
II. Nutritional megaloblastic anaemia (Vit B12 and folate deficiency) 
III. Mixed deficiency states (Dimorphic anaemia) 
b. Bone marrow failure 
1.  Aplastic anaemia  
 Congenital and acquired 
 Acquired 
2. Selective red cell aplasia: 
 Congenital  
 Diamond blacfan anaemia 
 Acquired  
Eg. Transient erythroblastopenia of childhood. 
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3. Marrow replacement  
 Myelofibrosis 
 Osteopetrosis 
 Maligancies 
c. Impaired erythropoiesis production  
 Chronic renal failure 
 Hypothyroidism and hypopituitarism 
 Chronic malnutrition 
d. Miscellanaeous:  
1. Congenital dyserythropoietc anaemia‟s 
2. Erythropoietic porphyria 
I. Disorders of increased RBC production:  
a. RBC membrane defects  
Eg. .Hereditary spherocytosis 
b. Defects of Haemoglobin synthesis  
i. Quantitative(Thalaseemia) 
 Alpha  
 Beta 
 Delta 
ii. Qualitative (Haemoglobinopathesis) 
Eg. Sickle cell disease HbE disease 
iii. Combined –Quantitative and Qualitativedefects 
 Hbs beta thalassemia 
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c. Defects of RBC enzymes 
 G-6-PD deficiency 
 Pyruate kinase deficiency 
d. Acquired defects: 
I. Immune haemolysis 
 Warm and cold antibody type  
 ABO and Rh incompactibility 
II. Infections 
 Malaria 
 Kala azar 
 Acute bacterial infections 
PATHOLOGICAL RED BLOOD CELLS IN ANAEMIA: 
 In anaemia, many kinds of abnormal red cells including nucleated forms are seen 
in the circulation. These abnormal cells are, 
I. Anisocytosis(Variation in the size of RBC) 
Macrocytosis, Microcytosis, Normocytosis  
II. Poikilocytosis (Variation in shape of RBC) 
Ovalocytosis, Spherocytosis, sickle cells 
III. Polychromatophilia (Irregularity in stainig) 
 This indicates an increase in immature red cells in circirculation and occurs 
in the following forms 
 Normoblasts, patchy staining of the cells, Punctate Basophilia (Basophilic 
stippling) and reticulocytes  
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IRON DEFICIENCY ANAEMIA 
Iron Deficiency Anaemia is the most common and wide spread nutritional 
disorder present throughout the world, but its prevalence is higher in developing 
countries. 
WHO estimates the number of anemic people worldwide to be a staggering two 
billion people and that approximately 50% of all anaemia can be attributed to iron 
deficiency. 
Malaria, HIV/AIDS, hookworm infestations, schistomiasis and other 
infections such as tuberculosis are particularly important factors contributing to the 
high prevalence of anaemia in some areas. 
40-50% of children and adult women were anaemic and that accounted for 
about 50% of anaemia in school children and women 80% in preschool children (2-5 
years old) 
According to third national family health survey (NFHS3) 
1. 79% of Indian children have anaemia including 
2. 7% of urban children and 84% of these in rural areas 
STRUCTURE OF THE RED CORPUSCLES IN IRON 
DEFICIENCY ANAEMIA: 
In iron deficiency anaemia the red blood corpuscles are decreased or normal in 
number and haemoglobin content of the red blood corpuscles is reduced. In blood 
smear, the red cells appear pale with a large central pale area and many of the red blood 
cells appear to be smaller than the normal. 
This type of anaemia is called Hypochromic and microcytic anaemia. 
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ETIOLOGY:- 
The Etiology varies with the age, sex and country of residence of the patients. 
ETIOLOGICAL FACTORS IN IRON DEFICIENCY ANAEMIA:- 
Increased physiological requirements: 
Rapid growth during infancy and pre adolescence. 
Decreased iron stores: 
Premature babies and twins 
Increased demand during: 
 Low birth weight,  prematurity, adolescence, recovery from PEM. 
Poor intake of dietary iron: 
Exclusive milk diet, restriction of calories. 
Poor absorption: 
Celiac disease, giardiasis, drug intake 
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Excess loss of iron : 
Blood loss during childbirth, gastrointestinal haemorrhage, faecal blood loss due to 
hookworm infestation, genitourinary bleed.  
Iron malabsorption: 
 Starch and clay eating produce malabsorption of iron and iron deficiency 
anaemia. 
 PICA increases the risk of helminths 
 Delayed weaning, infection and lead poisioning 
 Sprue, non-tropical sprue, chronic diarrhea, mille induced enteropathy. . 
 Rarely errors in metabolism as 
 Sideroblastic anaemia  
 Idiopathic pulmonary hemosiderosis 
 Congenital transferrin deficiency where iron gets stored in the body rather 
than being utilized for erythropoiesis 
Diminish absorption of iron: 
Phytates, oxalates, phosphates, carbonates and tannates 
Growth 
Iron deficiency anaemia is more in children between the ages of 6 months to 2 
years and from 11 to 16 years due to spurts of growth during these periods. 
Pathophysiology 
Diminished dietary absorption in proximal small intestine or excessive loss of 
body iron can result in iron deficiency 
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Iron deficiency anaemia develops when the supply of iron to the bone marrow is 
insufficient for the requirement of haemoglobin synthesis. 
Iron is required for multiple metabolic process including  
 Oxygen transport 
 DNA synthesis 
 Electron transport 
 In severe iron deficiency, the iron containing enzymes are low and this can 
affect immune and tissue function. 
 Iron deficiency anaemia can result in diminished growth /and learning and 
have serious consequences in children. 
 Healthy new born infants have a total body iron of 250mg (Approximately 
80 parts permillion ppm) this decreases to approximately 60 ppm in the first 
6 months of the life. 
 Body iron is regulated carefully by absorptive cells in the proximal small 
intestine, which alter iron absorption to match body losses of iron. 
 Breast milk iron content is more bioavailable than cow‟s milk. 
 Beside this fact, infants who consume cow‟s milk have more iron deficiency 
because bovine milk has a higher concentration of calcium which which 
competes with iron for absorption and they may have gastrointestinal blood 
loss due to cow‟s milk allergy. 
STAGES OF IRON DEFICIENCY ANAEMIA 
 On the basis of biochemical and haematological changes iron deficiency is 
graded into three stages 
Stage I – Depletion of iron store 
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 Ferritin is decreased, transferrin saturation, serum iron and haemoglobin are 
normal 
Stage II- Depletion of transport iron transferrin saturation and serum iron also 
reduced. Haemoglobin is normal. 
Stage – III – State of IDA 
Frank features of IDA 
The flow of iron to erythroid marrow is impared to cause reduction in 
haemoglobin concentration with a progressive microcytic hypochromic anaemia 
associated with the reduced serum iron transferrin saturation and serum ferritin level. 
CLINICAL FEATURES:-  
Symptoms: 
 Irritability 
 Anorexia  
 Easy fatigability 
 Tiredness/ weakness  
 Diarrhoea is often present  
 Leg cramps  
 Palpitations 
 Inability to concentrate, somnolence, giddiness. 
 Features of causative condition for example epigastric pain (Peptic ulcer) 
 Constipation 
 History of PICA 
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 Lack of memory 
Signs: 
 Eyes- Pallor in conjuntiva 
 Nails- Pallor, Koilonychias (spoon shaped nails) and platynychia (flat nails) 
 Hair- Dry, lusterless, excess loss of scalp hair   
 Mouth-  Bald, atrophy of tongue papillae glossitis, angular stomatitis 
 Abdomen – Mild hepatomegaly is common in children. 
ROLE OF IRON DEFICIENCY ANAEMIA IN VARIOUS 
SYSTEMS 
Cardiovascular system:- 
 Dyspnoea and pslpitstionsre common symptoms but in very severe anaemia the 
patient may get congestive cardiac failure. Haemic murmurs are commonly heared in 
anaemic patients. 
Respiratory system:- 
 Dyspnoea and respiratory infections 
Central nervous system:- 
 Symptoms include faintness, giddiness, headache, lack of concentration and 
drowsiness with severe anaemia, clouding of consciousness, numbness and sometimes 
tingling of hands and feet. 
Renal system:-  
Slight protenuria may be present with severe anaemia 
Gastrointestinal system:- 
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 Anorexia is the commonest system nausea, flatulence and constipation may also 
occur slight to moderate smooth hepatomegaly is common in severe anaemia. Liner 
may become tender. In certain cases of iron deficiency anaemia, spleen may be 
enlarged. 
DIFFERENTIAL DIAGNOSIS OF MICROCYTIC 
HYPOCHROMIC ANAEMIA 
 Thalassaemia 
 Pyridoxine deficiency 
 Lead poisioning 
 Chronic infection  
 Sideroblastic anaemia 
 Congenital atransferrinemia 
 Copper deficiency  
 G6PD deficiency 
COMPLICATIONS: 
 Infections are more common in iron deficiency anaemia, especially those of 
respiratory, gastrointestinal and urinary tracts. 
 Chronic iron deficiency anaemia reduces the efficiency in work and study 
 CCF 
INVESTIGATIONS: 
 Complete blood count with blood indexes 
 RBC count decreased, WBC  count normal 
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 Low –mean corpuscular volume (MCV), mean corpuscular 
haemoglobin(MCH) and mean corpuscular haemoglobin concentration 
(MCHC) 
 Peripheral blood smear –RBCs are microcytic hypochromic and show 
anisocytic, poikilocytosis 
 Normal reticulocyte count  
 Serum iron level -  Less than 60g/dl 
 Total iron binding capacity(TIBC) - >350g/dl 
 Transferrin saturation - <16% (Normal range-25% -50% ) 
 Serum ferritin - Low 
 Free erythrocyte protoporphyrins(FEP)- increased 
 Normal 30 – 40% g/dl 
 70g/dl indicate IDA 
 Stainable iron in marrow- low 
 FEP/Haemoglobin ratio increases.  Normal ratio 60 : 1 
 Iron containing enzymes such as monoamine oxidase, catalase, cytochrome 
peroxidase s will be – low 
 Investigation to determine the cause  of anaemia, 
 Stool examination – stools for occult blood, ova, cyst (hookworms). 
 Gastrointestinal studies for bleeding, polyp, etc.-  
 Barium meal examination, upper/ lower GI endoscopy, etc.   
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DIAGNOSIS: 
Following criteria are essential to diagnose iron deficiency anaemia 
 History of inadequate intake of dietary iron and blood loss if any. 
 Hypochromic and microcytic structure of red blood cells. 
 Low serum iron, increased total iron binding capacity. 
 Platelet count is either normal or raised. 
 Haemoglobin estimation variably reduced 
 Reduced mean cell volume 
 Erythrocyte count may be normal or reduced less than haemoglobin level would 
suggest. 
 Serum ferritin level is reduced 
 Clinical features of anaemia. 
MANAGEMENT: 
 Treat the cause 
 Increase the iron intake  
 Increase iron absorption 
 Overall correction of nutrition with food articles rich in iron is most 
important. Meat, liver, green leafy vegetables, onion, grapes, and jaggery 
are good source of iron. 
 There are two forms of dietary iron heme and non heme. 
 Vitamin c help absorb the non heme iron. Food containing non heme iron 
and the vitamin C rich food are eaten at the same meal.       
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PREVENTION: 
This is a condition which can be prevented easily by supplementing iron rich foods. 
This involves the following measures: 
 Eating diet with a wide variety of iron containing food 
 Fortification of articles of food such as bread, salt, wheat and flour 
 Improvement of personal hygiene 
 Avoiding open air defecation (ankylostomiasis) 
 Wearing foot wear 
 Frequent deworming  
 Iron supplementation during pregnancy, lactation and childhood.   
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TRIAL MEDICINE 
 
 
 
 
 
 
 
 
 
 
 
 
CHITRAMUTTI NEI 
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                  INGREDIENTS OF CHITRAMUTTI NEI 
 
 
 
 
 
Terminalia chebula                                                     Terminalia belirica 
 
 
 
 
 
 
             Curcuma longa                                                  Phyllanthus Emblica 
 
 
 
 
 
Sida cordifolia                               Andrographis paniculata 
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COW GHEE 
 
 
 
Madhuca longifolia 
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PREPARATION AND PROPERTIES OF TRIAL DRUGS 
CHITRAMUTTI NEI 
Ref: Chikicha Rathna Deepam (Page No:212, 213) 
Pub: B.Rathina Nayakar And Sons, Chennai-79,Edition-2011 
INGREDIENTS: 
 Chitramutti ver (Sida cordifolia) 
 Karimanjal  (Curcuma longa) 
 Kadukkai    (Terminlia chebula) 
 Thandrikkai    (Terminalia belirica) 
 Nellivatral     (Phyllanthus emblica) 
 Nilavembu    (Andrographis paniculata) 
 Illupai verpattai  (Madhuca longifolia) 
 Cow‟s milk 
 Ghee 
Source of raw drug: 
 The required raw drugs are procured from a well reputed indigenous drug shop. 
Fresh specimen of Chitramutti root was collected from Siddha medicinal plant garden, 
Mettur, Salem, Tamil Nadu with concerned of Botanist. Illupai ver pattai was collected 
from my native place, Pondicherry. Then the raw drugs were authenticated by the 
concerned Pharmacognosist, SCRI, Chennai. 
Purification: 
   Fresh specimen of Chitramutti root, Illupai ver pattai were dried in sunlight for 1 
month. The drugs were purified and all drugs were taken in an equal quantity of 
280gram. 
Preparation: 
The purified drugs were made into coarse powdered. The coarse powdered drugs were 
put in pot and 5.2 lit of water was added and made into a half the amount(2.5lit). Then 
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cow‟s milk 5 lit, ghee 1.5lit were added to the above decoction and heated upto ghee 
form and then filtered it. 
Drug Storage: 
The trial drug is stored in clean dry air tight container and it is dispensed to the patients 
in air tight bottle. 
Dose: 4-5 ml, Twice a day 
Duration: 28 days. 
PROPERTIES OF TRIAL DRUG 
rpw;whKl;b 
Botanical Name :  Sida cordifolia 
English Name : Yellow Sticky Mallon 
Family  : Malvaceae 
Suvai   : Thuvarpu 
Thanmai  : Thatpam 
Pirivu   : Inippu  
Part used  : Whole plant 
ப ொதுகுணம்: 
“mj;jp RuKjy; mde;jRuk; gpj;jKk; Nghk; 
nkj;j tpopf;nfhspahk; tPWjap- yj;jpw;fhk; 
ew;wh kiuj;jpUT ehL nkopw;wpUNt! 
rpw;whKl; bj;Jiur; nrg;G.” 
                   -mfj;jpah; Fzthflk; 
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Chemical constituents:  
Ephedrine, Pseudoephedrine, malvalic and coronaric acid, Fatty acids, Saponine, Indole 
alkaloids, Palmitic acids, Stearic and  - sitosterol.  
Actions:  
Emollient, Tonic, Stomachic, Astringent. 
Pharmacological activities:  
Anti oxident.Anti- helminthic, Hepatoprotective, anti – microbial, Wound healing. 
fwpkQ;rs; 
Botanical Name :  Curcuma longa 
English Name : Turmeric 
Family  : Curcurbitaceae 
Suvai   : Kaarpu, Kaippu 
Thanmai  : Veppam 
Pirivu   : Kaarpu 
Part used  : Rhizome 
ப ொதுகுணம்: 
“nghd;dpwkhk; Nkdp Gyhdhw;w Kk;NghFk; 
kd;D GUl trpakhk;- gpd;dpnaOk;  
the;jpgpj;j Njhlikak; thjk;Nghe; jPgdkhq; 
 $h;e;jkQ;r spd;fpoq;Ff;F” 
                    -mfj;jpah; Fzthflk; 
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Chemical constituents:  
                        Ar- turmerone,  turmerone,  turmerone,  ocimene,  phellandrene, 
Terpinolene, 1,8 Cineole, Undecanol, p- cymene. 
Actions: 
Aromatic, stimulant, carminative, Stomachic, Tonic 
Pharmacological activities: 
Anti tumour, Anti fungal, .Anti- helminthic, Hepatoprotective, anti – microbial, Wound 
healing, Anti oxident. 
fLf;fha;j;Njhy; 
Botanical Name :  Terminalia chebula 
English Name : Chebulic Myrobalan 
Family  : Combretaceae 
Suvai   : Kaarpu,  
Thanmai  : Veppam 
Pirivu   : Innipu 
Part used  : Fruits 
ப ொதுகுணம்: 
“jhil fOj;jf;fp jhY Fwpaptplg; 
gPil rpypgjKw; NgjpKlk;- Milnal;lhj; 
J}ykpb Gz;thj Nrhzpfh khiyapuz; 
  Lhykpb Nghk;thpf;fh ahy;” 
                    -mfj;jpah; Fzthflk; 
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Chemical constituents:  
        Chebulic acid, Chebulagic acid, Corilagin, Gallic acid, Mannitol, Ascorbic acid, 
Actions: 
Astringent, Alternative Stomachic, Tonic  
Pharmacological activities: 
 Anti viral, .Anti- helminthic, Hepatoprotective, anti –bacterial, Anti oxidant. 
             jhd;wpf;fha; 
Botanical Name :  Terminalia bellirica 
English Name : Belleric Myrobalan 
Family  : Combretaceae 
Suvai   : Thuvarpu 
Thanmai  : Veppam 
Pirivu   : Innipu 
Part used  : Fruits 
ப ொதுகுணம்: 
“Mzpg;nghd; Nkdpf; foFk; xspAkpFk; 
           Nfhzpf;nfhs; thjgpj;jf;nfhs;ifNghk;-jhdpf;fha; 
 nfhz;lth;f;F NkfkWk; $wh mdw;wzpAk; 
 fz;lth;f;F thjk;Nghk; fhz;” 
                    -mfj;jpah; Fzthflk; 
Chemical constituents:  
                Glucoside, Gallo-tannic acid, Ellagic acid, Gallic acid, Ethyl gallate, Galloyl 
glucose, Chebulagic acid, - sitosterol, Mannitol,Glucose.  
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Actions: 
Astringent, Expectorant, Laxative, Tonic 
Pharmacological activities:  
Anti Diarrhoeal, .Anti- helminthic, Hepatoprotective, anti –microbial, Anti oxidant, 
Wound healing, Immunomodulatory, Anti pyretic. 
ney;yptw;wy; 
Botanical Name :  Phyllanthus emblica 
English Name : Indian Goseberry 
Family  : Euphorbiaceae 
Suvai   : Thuvarpu, pullipu,Innipu 
Thanmai  : Thatpam 
Pirivu   : Innipu 
Part used  : Fruits 
ப ொதுகுணம்: 
“ney;ypf;fha;f; Fg;gpj;jk; ePq;F kjd;Gspg;ghy; 
nry;YNk thjkjpw; Nrh;Jtuhy;-nrhy;Yikak; 
XLkpijr; rpj;jj;jpy; cd;d mdYlNd 
$Lgpw NkfKk; Nghq; $W” 
                           -Njud; Fzthflk; 
Chemical constituents:  
Vitamin C- 600mg/100g, Iron- 1.2mg / 100mg, Glucoside, Ellagic acid, Gallic 
acid, 1-0 Galloyl-beta-D- glucose, Chebulagic acid, Chebulinic acid, Quercetin, 
Corilagin.  
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Actions: 
Refrigerant, Diuretic, Laxative, Carminative, Stomachic. 
Pharmacological activities:  
Cardio protective,.Anti- helminthic, Hepatoprotective, anti –microbial,Memory 
enhancer, Hair growth property, Immunomodulator, Anti pyretic. 
epyNtk;Gr; r%yk; 
Botanical Name :  Andrographis paniculata 
English Name : Green chiretta kalmegh, Creat 
Family  : Acanthaceae 
Suvai   : Kaippu 
Thanmai  : Veppam 
Pirivu   : Karppu 
Part used  : Whole plant 
ப ொதுகுணம்: 
               “thjRuk; ePNuw;wk; khw;WQ; RuNjhNl 
fhjnkd Xlf; fbAq;fhz;-khjuNr! 
          gpj;j kaf;fWf;Fk; gpd;Gnjsp itf;nfhLf;Fk;  
          Rj;jepy Ntk;gpd; njhopy;” 
                    -mfj;jpah; Fzthflk ; 
Chemical constituents:  
Andrographide 1, 14-Deoxyandrographide 3,Neoandrographide, Andrographiside 8, 
Homoandrographolide, Andrographosterol,  sitosterol, andrographin.  
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Actions: 
       Astringent, Stimulant, Alternative, Tonic 
Pharmacological activities: 
Anti- helminthic, Hepatoprotective, anti –bacterial, Anti oxidant,  
Immunological, Anti pyretic. 
,Yg;ig Nth;g;gl;il 
Botanical Name :  Madhuca longifolia 
English Name : South Indian Mahua 
Family  : Sapotaceae 
Suvai   : Thuvarpu 
Thanmai  : Thatpam 
Pirivu   : kaarppu 
Part used  : Root Bark 
ப ொதுகுணம்: 
“Gz;Zk; GiuAkWk; Nghjj; Jth;g;ghFk; 
vz;Zkff;fLg;gp Uf;FNkh-ngz;Nz Nfs; 
ePhpopT NkFk; neLNkhik %yj;jhs; 
Nghulh;f Lg;gpuj;jk; Nghk;” 
                    -mfj;jpah; Fzthflk; 
Chemical constituents:  
-D-Glucoside of  -sitosterol, Erythrodiol 3-caprylate, Oleanolic acid, 
stigmasterol  
Actions: 
Astringent, Alternative, Stimulant, stomachic, Tonic 
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Pharmacological activities:  
Anti- helminthic, Hepatoprotective, anti –microbial, Anti oxidant, Wound 
healing, Anti pyretic. 
gRtpd; ghy; 
NtWg;ngah;: 
gak>; fPuk;> Rij> gaR> ghF> mKJ> Jj;jk; rhW. 
ப ொதுகுணம்: 
“ghyh; fpoth; goQ;Ruj;Njhh; Gz;zhsp 
#iyah; Nkfj;Njhh; Jh;gyj;Njhh; VYkpth; 
vy;yhh;f;F khFk; ,isj;jth;f;FQ; rhjfkha; 
ey;yha; gRtpd;ghy; ehl;L” 
USES: 
 Sweet in taste, heavy to digest, has coolent effect on the body. 
 Improves immunity of the body 
 Nourishes the boy tissues 
 Does rejuvenation, increase life expectancy 
 Improves intelligence, strength. 
 Assist in easy movement of intestines. 
 Relives tiredness, dizziness, excessive thirst, hunger 
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                                        COW GHEE 
Suvai  : Inippu 
Thanmai :Thatpam 
Pirivu  :Inippu 
Qualities :light, substle 
Actions on the doshas:  
         Tridoshaic – balance vatha, pitha kabha. 
Chemical composition: 
Cow Ghee‟s is abdudant in saturate fatty acids. It contains approximately 8% 
saturated fatty acids which make it easily digestible.The digestible co-efficient or the 
rate absorption is 96% which is better than any other animal or vegetable fat. 
              It contain triglyceride, diglycerides, monoglyceride, phospholipids contains 
beta carotene 600 IU and vitamin E which are known as Anti oxidant. 
Action: 
Anti fungal, Anti oxidant, anti aging, Anti bacterial, Antiviral 
Medicinal qualities: 
 It increase our capacity to digest food but also our capacity to absorb and 
assimilate it 
 It is cooling, tasty, tonic, appetizer. 
 It directly nourishes our immune system, as well as our life force and all of our 
tissues. 
 It increases intelligence, refines the intellect and improves the memory. 
 Ghee increase the strength, luster and beauty of the body. 
 It  can stimulate secretion of stomach acids and thus helping in the digestive 
process. 
 It increase the absorbability of vitamins and minerals and thus help to improve 
overall health.it balances all Agni (digestive fires). 
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4. MATERIALS AND METHODS 
STUDY DESIGN: 
            An open clinical trial on Paandu Noi was carried out in the OP of P.G 
Kuzhanthai Maruthuvam  Department attached to Aringnar Anna Hospital of Indian 
Medicine, Chennai-106 during the period  2015 – 2017. 
            The study was approved by Institutional Ethical Committee (IEC) and 
approval number is GSMC-CH-ME-4/019/2015. 
POPULATION AND SAMPLE: 
The population consists of all patients satisfying the inclusion and exclusion criteria 
mentioned below. Sample consists of Paandu Noi patients who were attending the OP 
of Aringnar Anna Hospital, Arumbakkam, Chennai -106. 
SAMPLE SIZE: 
         The study is conducted in 40 selected patients of both genders between age 
groups of 3 – 12 years. 
INCLUSION CRITERIA:  
 Age: 3 -12 years; Sex – both male & female children 
 Hb level between 7 – 11gms 
 Sign of pallor of skin, conjunctiva, mucous membrane, nail beds 
 Anorexia, fatigue, dyspnoea on  exertion, palpitation 
 Angular stomatitis 
 Loss of memory, lack of interest, frontal headache 
 Worm infestation    
 Patients who undergo routine blood investigation  
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EXCLUSION CRITERIA: 
 Known H/O of Metabolic disorder 
 Known H/O of Haemolytic  anaemia  
 Known H/O of Thalessemia 
 Patient with chronic disease 
 Patient with any other serious illness. 
WITHDRAWAL CRITERIA: 
 Exacerbation of symptoms. 
 The subject develops adverse drug reactions and adverse event they will be 
withdrawn from the trial. 
 Patient turned unwilling to continue in the course of clinical trial. 
EVALUATION OF CLINICAL PARAMETERS: 
Patients are clinically evaluated by using the following parameters 
History taking: 
Age, occupation, Socio economic status, complaints and duration, past illness, 
family history, and  personal habits were recorded in the case sheets for every patients 
during his / her first visit to OP. 
INVESTIGATIONS: 
Blood: 
TC, DC, ESR, Hb 
URINE: 
Albumin, Sugar,Deposit 
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SPECIFIC IVESTIGATIONS: 
Blood: 
PCV, MCV, MCH, MCHC, Total RBC 
MOTION: 
Ova, Cyst, Occult blood 
CLINICAL DIAGNOSIS BASED ON SIDDHA SYSTEM: 
The parameters used to diagnose the disease paandu Noi in siddha system are as 
follows, 
 Poriyal aridhal 
 Pulanaal aridhal 
 Vinaadhal 
 Uyirthathukkal 
 Udalthadhukkal 
 Envagaithervu 
METHODOLOGY OF TREATMENT: 
Study Enrollment: 
Patient reporting at the OPD associated with clinical features of Pallor in 
conjuctivia & mucous membrane, Headache, Fatigue, Loss of appetite, worm 
infestation, dyspnoea on exertion, constipation are chosen for enrolment based on the 
inclusion criteria. The patients who are enrolled are informed about the study trial drug 
Chitramutti Nei, possible outcomes and the objectives of the study in the language and 
terms understandable to them and then informed consent/assent would be obtained 
from the patient/patients parent using consent/Assent form. 
Conduct of the Study: 
On the first day onwards the trial drug “Chitramutti Nei” (InternaL) will be 
given. The trial drug will be given in the OPD department of Kuzhanthai Maruthuvam, 
GSMC, Chennai. The patients will be asked to have a regular follow up in the OPD 
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department once in 7days. In each and every visit the clinical assessment will be 
recorded in the prescribed proforma.The laboratory investigation will be done before 
and after treatment and recorded in the prescribed format. 
Data collection forms: 
Required information will be collected from each patient by using following 
forms. 
Form I  : Screening and selection proforma. 
Form II    : History taking proforma. 
Form III    : Clinical assessment proforma. 
Form IV    : Clinical assessment during and after trial. 
Form V     : Laboratory Investigation proforma. 
Form VI    : Informed consent/Assent form. 
Form VII   : Withdrawal form. 
Form VIII : Patient information sheet. 
Data Analysis:  
 After enrolling the patients in the study, a separate file for each patient will be 
maintained and all forms will be kept in the file. Whenever the patient visits OPD 
during the study period, necessary entries will be made in the assessment forms. 
 The data entries and adverse events if any will be monitored by the Head of the 
Department. 
OUTCOME OF TREATMENT: 
Primary Outcome: 
 Primary outcome is mainly assessed by reduction in clinical symptoms and by 
Raising Hb above 3 g/dl and comparing the following parameters before and after 
treatment. 
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Secondary Outcome: 
Secondary outcome is assessed by comparing the safety parameters before and after 
treatment. 
Adverse Effect and Serious Effect Management: 
             If the trial patient develops any adverse reactions the patient will be referred to 
the Pharmacovigilance department of SCRI and documented. For any adverse effect the 
investigator will give the proper management in the OPD. 
ETHICAL ISSUES 
1. Informed consent/Assent will be obtained from the patient/patient‟s parent or 
guardian after explaining about the clinical trial in an understandable language. 
2. After the consent/Assent of the patient or patient‟s parent(through 
consent/Assent) if they fit in the criteria they will be enrolled in the study. 
3. Treatment will be provided free of cost. 
4. Concomitant medicines will be used if there is any need. 
5. The patients who are excluded (as per the exclusion criteria)will be refer to 
OPD. 
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RESULTS AND OBSERVATION 
A total number of 40 child patients with signs and symptoms of 
PaanduNoiattending PG-IV, KuzhanthaiMaruthuvam, Out Patient Department in Govt. 
Siddha Medical College attached to Aringnar Anna Hospital during 2015- 2017 were 
observed in the present study. The observations were made and tabulated with regards 
to the following features:  
1. Age Distribution 
2. Gender Distribution 
3. Socio-Economic status 
4. Aetiological factor 
5. Dietary habits 
6. Seasonal reference 
7. Reference to Thinai 
8. UyirThathukkal 
9. Udarthathukkal 
10. Envagaithervugal 
11. Neikkuri 
12. Clinical prognosis 
13. Results after treatment 
The observation recorded are given below in tabular form 
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AGE DISTRIBUTION 
S.NO.  AGE   
NO. OF 
CASES  
PERCENTAGE 
1 3-5 yrs 12 30% 
2 5-7 yrs 8 20% 
3 7-10 yrs 14 35% 
4 10-12 yrs 6 15% 
 
 
Inference  
The above table indicates that children coming under 3-5 years of age group 
were 12(30%), 5-7 years were 8(20%), 7-10 years were 14(35%), 10-12 years were 6 
(15%) respectively. 
3-5 yrs 5-7 yrs 7-10 yrs 10-12 yrs
30%
20%
35%
15%
AGE DISTRRIBUTION
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SEX DISTRIBUTION 
S.NO. SEX 
NO. OF 
CASES 
PERCENTAGE 
1 
Male 
child 
16 40% 
2 
Female 
child 
24 60% 
 
 
Inference 
 Among the 40 cases for this present study, 24 (60%) children were female and 
16 (40%) children were male. According to modern theory there is no apparent sex 
prediction. 
 
 
Male child 
40%Female child 
60%
SEX DISTRIBUTION
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SOCIO ECONOMIC STATUS 
 
S.NO. STATUS 
NO. OF 
CASES 
PERCENTAGE 
1 Rich 2 5% 
2 Middle 12 30% 
3 Poor 26 65% 
 
 
 
Inference: 
Regarding socio-economic status, 26(65%) cases were belong to poor status, 
12(30%) cases were belong to middle class and 2(5%) cases belong to high class. 
 
 
5%
30%
65%
SOCIOECONOMIC STATUS
Rich 
Middle 
Poor 
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AETIOLOGICAL FACTOR: 
S.NO AETIOLOGY NO OF CASES PERCENTAGE 
1 Nutritional deficiency 10 25% 
2 Worm infestation 30 75% 
 
 
 
 
INFERENCE: 
Among 40 cases, 10 (25%) cases were due to nutritional deficiency, 30 (75%) 
cases were due to Worm infestation  
 
 
 
25%
75%
AETIOLOGICAL FACTOR
Nutritional deficiency
Worm infestation
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DIETARY HABITS: 
S.NO DIET NO. OF CASES PERCENTAGE 
1. Vegetarian 4 10% 
2 Mixed 36 90% 
 
 
 
 
Inference: 
90% belonged to mixed diet and 10% belonged to vegetarian diet 
habit. 
 
 
Vegetarian Mixed
10%
90%
DIETARY HABIT
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SEASONAL REFERENCE: 
S.NO. KAALANGAL  NO.OF CASES PERCENTAGE 
1 Kaar(Aavani, purattasi) 1 2.5% 
2 Koothir (Iypasi, karthigai) 2 5% 
3 Munpani (Margazhi, Thai) 21 52.5% 
4 Pinpani (Masi, Pankuni) 14 35% 
5 Elavenil (Chithirai, Vaikasi) 2 5% 
6 Muduvenil (Aani, Aadi) 0 0% 
 
 
Inference 
 Regarding Paruvakaalam among 40 cases, 1(2.5%) cases were reported in 
Kaarkaalam, 2(5%) cases were reported in Koothirkaalamand ElavenilKaalam, 
Kaar Koothir Munpani Pinpani Elavenil Muduvenil 
2.50%
5%
52.50%
35%
5%
0%
SEASONAL REFERENCE
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21(52.5%) cases were reported in Munpanikaalam, 14(35%) cases were reported in 
Pinpanikaalam and no cases were reported in Muduvenilkaalam respectively 
 
REFERENCE TO THINAI: 
S.NO. NILAM  NO. OF 
CASES 
PERCENTAGE 
1 Kurinchi 0 0% 
2 Mullai 0 0% 
3 Marutham 0 0%` 
4 Neithal 40 100% 
5 Paalai 0 0% 
 
 
 
Inference 
 Among the 40 cases reported were from surroundings of Chennai which 
belongs to Neithalnilam.It cause increase in pitham 
Kurinchi Mullai Marutham Neithal Paalai
0% 0% 0% 0%
THINAI
100%
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UYIR THATHUKKAL: 
a. AFFECTED VATHAM: 
S.No. Vatham No. of cases Percentage 
1 Praanan 40 100% 
2 Abaanan 26 65% 
3 Vyanan 40 100% 
4 Udhanan 40 100% 
5 Samaanan 40 100% 
6 Naagan 0 0% 
7 Koorman 0 0% 
8 Kirukaran 40 100% 
9 Devadhathan 40 100% 
10 Dhananjayan 0 0% 
 
 
Inference: 
In 40 cases, among 10 types of Vaatham, Praanan, Viyaanan,Udhanan Samaanam, 
Kirukaran and Devathathan were affected in all 40 cases (100%). Abaanan was 
affected in 26 cases(65%) respectively. 
100%
65%
100% 100% 100%
0% 0%
100% 100%
0%
VATHAM
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PITHAM 
S.NO.  PITHAM  NO. OF CASES  PERCENTAGE  
1 Anal Pitham 40 100% 
2 RanjagaPitham 40 100% 
3 SaathagaPitham.  40 100% 
4 PrasagaPitham 40 100% 
5 AalosagaPitham 0 0% 
 
 
 
INFERENCE: 
Among 5 types of Pitham all was affected, except Aalosagam  in all patients. 
  
100% 100% 100% 100%
0%
PITHAM 
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KABAM 
S.NO. KABAM NO. OF CASES PERCENTAGE 
1 Avalambagam 40 100% 
2 Kilethagam 40 100% 
3 Pothagam 0 0% 
4 Tharpagam. 0 0% 
5 Santhigam 0 0% 
 
 
 
INFERENCE: 
Among 40 cases, Aavalamgam was affected in 16 cases (40%) and Kilathagam was 
affected in all the cases. 
 
Avalam 
bagam
Kilethagam Pothagam Tharpagam. Santhigam
100% 100%
0% 0% 0%
KABAM
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UDARTHATHUKKAL 
S.NO. NAME   NO. OF CASES PERCENTAGE 
1 Saaram 40 100% 
2 Senneer 40 100% 
3 Oon 0 0% 
4 Kozhuppu 0 0% 
5 Enbu 0 0% 
6 Moolai 0 0% 
7 Vindhu / Naatham 0 0% 
 
 
 
INFERENCE: 
InUdalthathukkal, Saaram and Senner were affected in all 40(100%) cases. 
 
Saaram Senneer Oon Kozhuppu Enbu Moolai Vindhu / 
Naatham
100% 100%
0% 0% 0% 0% 0%
UDARTHATHUKKAL
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ENVAGAI THERVUGAL: 
S.NO. SIDDHA 
PARAMETERS 
NO. OF CASES PERCENTAGE 
1 Naa 40 100% 
2 Niram 40 100% 
3 Mozhi 0 0% 
4 Vizhi 40 100% 
5 Sparisam 12 30% 
6 Malam 26 65% 
7 Moothiram 0 0% 
8 Naadi   
a)Pithavaatham 20 50% 
b)vathakabam 
c Kabapitham 
9 
11 
22.5% 
27.5% 
 
 
Inference: 
Among the Ennvagaithervukal, Naa, Niram and Vizhi were affected in all cases 
(100%). In 26 cases (65%) Malam, and in 12 cases (30%) Sparism were affected and in 
Naadi 20 cases (50%) Pithavaatham, in 10 cases (22.5%) vathakabam and in 11 cases 
(27.5%)  Kabapitham were affected.   
100% 100%
0%
100%
30%
65%
0%
50%
23% 28%
ENVAGAI THERVUGAL
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NEIKKURI 
 
 
TYPE OF NEER  CHARACTER  NO. OF CASES & 
PERCENTAGE 
1 Vathaneer Aravenaneendal 8(20%) 
2 Pithaneer Aazhipolparavuthal 22(55%) 
3 Kabaneer Muththothunitral 10(25%) 
 
 
Inference 
 Among 40 cases, Vathaneerwas observed in 8(20%) cases, Pithaneerwas 
observed in 22(55%) cases, Kabaneerwas observed in 10(25%) cases. 
 
 
Vathaneer Pithaneer Kabaneer
20%
55%
25%
NEIKURI
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REFERENCE TO CLINICAL PROGNOSIS 
 
S. 
NO 
Clinical features 
Before Treatment After Treatment 
No.of 
cases 
Percentage 
No.of 
cases 
Percentage 
1 
Pallor of conjunctivae, 
tongue, nail beds 
40 100% 10 25% 
2 Anorexia 40 100% 0 0% 
3 Fatigue / Lassitude 40 100% 4 10% 
4. Constipation 26 65% 0 0% 
5 
Lack of interest & 
concentration 
20 50% 6 15% 
6 Dyspnoea on exertion 40 100% 6 15% 
7 Weight loss 17 43% 2 5% 
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Inference 
 The above table reveals that, among all the 40 cases Anorexia was reduced, 
pallor of conjunctivae, tongue nail beds was reduced in 30 cases among 10, fatigue was 
reduced in 36 cases  among 40, constipation was reduced in all cases, lack of interest / 
concentration was reduced in 14 cases among 20, dyspnoea on excertion was reduced 
in 34 cases among 40, weight loss was reduced in 15 cases among 17. 
 
 
 
 
 
 
40 40 40
26
20
40
17
10
0
4
0
6 6
2
CLINICAL PROGNOSIS
Before Treatment After Treatment
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RESULTS AFTER TREATMENT 
Results were observed on the basis of two main criteria. One on tbe basis of 
clinical improvement and the other on the results derived from the blood picture. 
a. Results from  clinical improvement 
Good, Moderate, Mild improvements were assessed on the basis of relieved 
signs and symptoms as follows. 
Good improvement 
 Anorexia – nil 
 Lassitude – nil 
 Pallor of conjunctiva and nail beds – nil 
 Dyspnoea on exertion – nil  
 Lack of interest / concentration – improved 
Moderate improvement 
 Anorexia – nil 
 Lassitude – nil 
 Pallor of conjunctiva and nail beds – improved 
 Dyspnoea on exertion – moderately improved  
 Lack of interest / concentration – slightly improved 
Mild improvement 
 Anorexia – nil 
 Lassitude – present or absent 
 Pallor of conjunctiva and nail beds – present 
 Dyspnoea on exertion – present 
 Lack of interest / concentration – present 
Among the 40 cases, 27 cases assessed as good improvement, 8 cases assessed as 
moderate improvement, and 5 cases assessed as mild improvement. 
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b. Results derived from the blood picture 
Good:  Increase  in  Hb level  between 3gms/dl  and above after  treatment . 
Moderate: Increase  in Hb level between 2gms/dl to 2.9 gms/dl after  treatment 
Mild: Increase  in Hb level between 0.5gms/dl to 1.5gm/dl  after  treatment 
Among the 40 cases studies the result were observed as follows 
S.NO RESULTS NO.OF CASES PERCENTAGE 
1 Good 24 60% 
2 Moderate 10 25% 
3 Mild 6 15% 
 
Inference: 
Among the 40 cases treated, 24 cases (60%) showed good result, 10 cases 
(25%)  showed moderate result and 6 cases (15%) showed mild result. The results were 
based on clinical improvement and results derived from the blood picture.  
 
  
RESULTS
Good
Moderate
Mild
6o%
15%
25%
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CASE SUMMARY OF THE PATIENTS 
S.NO OP.NO NAME AGE/ SEX REMARKS 
1 8512 Logithashva 6 /MC MILD 
2 881 Harini 5/ FC GOOD 
3 1024 Jayalakshmi 9/ FC GOOD 
4 5230 Nishanthini 12/FC MILD 
5 5251 Suganthan 6/MC MODERATE 
6 5587 Sham prabhakaran 8/MC MODERATE 
7 5569 Jeevalakshmi 12/ FC GOOD 
8 5567 Thamaraiselvi 9/FC GOOD 
9 6096 Lakshya 4/FC GOOD 
10 6204 Parameshwari 10/ FC MODERATE 
11 7293 Kaviya 4/FC GOOD 
12 7341 Naveenshiva 5/MC GOOD 
13 7560 Yuvashree 12/ FC MILD 
14 7479 Tamilselvam 8/MC MODERATE 
15 8111 Kirthika 4/FC MILD 
16 8291 Joseph 7/MC GOOD 
17 8903 Sherlin 5/MC GOOD 
18 179 Shemirna 12/FC GOOD 
19 4172 Sakithi 5/FC GOOD 
20 4228 Merlin Jones 9/FC GOOD 
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S.NO OP.NO NAME AGE/ SEX REMARKS 
21 5412 Pavithra 6/FC MILD 
22 6626 Jayabharathi 8/FC GOOD 
23 7119 Harikrishnan 8/MC GOOD 
24 12 Sondariya 8/FC MODERATE 
25 9897 Jagatheshkumar 10/MC MODERATE 
26 234 Devakar 3/MC MODERATE 
27 252 Hariba 9/FC MODERATE 
28 685 Uthrapathi 6/MC GOOD 
29 732 Pooja 8/FC MODERATE 
30 749 Lithisha 3/FC GOOD 
31 1178 Ariys 3/MC MILD 
32 2706 Shamsundar 9/MC GOOD 
33 3470 Nithilash 8/MC GOOD 
34 3971 Thiyaammi 6/FC GOOD 
35 8470 Jaganan 7/MC GOOD 
36 9460 Sumaiya 12/FC GOOD 
37 9889 Harrisraj 11/MC MODERATE 
38 3857 Anika 7/FC GOOD 
39 8616 Kaviyashree 5/FC GOOD 
40 8681 Saitharun 4/MC GOOD 
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BT- Before Treatment, AT- After Treatment, N-Nil, TC-Total Blood Count, DC-Differential Blood Count,P-Polymorphs, L-Leucocytes, E-
Eosinophils, ESR-Erythocyte Sedimentation Rate, mm-Milimeter, Hb-Hemoglobin, Alb-Albumin, Sug-Sugar, Dep-Deposits, FEC-Few 
Epithelial Cells, FP- Few pus cell    
 
S.No. OP.No. 
Age  / 
Sex 
Before Treatment After Treatment ESR (mm) Urine Analysis 
TC 
DC 
TC 
DC BT AT BT AT  
P% L%  E% P% L%  E% ½ Hr 1 Hr ½ Hr 1 Hr Alb Sug Dep Alb Sug Dep 
1. 8512 6/MC 7400 56 42 2 7900 57 43 3 13 28 9 6 N N N N N N 
2. 881 5/FC 8900 43 50 7 9100 45 52 4 5 20 2 3 N N N N N N 
3. 1024 9/FC 9700 62 31 6 9900 63 33 3 15 20 8 12 N N N N N N 
4. 5230 12/FC 8300 49 45 6 8500 51 46 3 12 30 6 18 N N N N N N 
5. 5251 6/MC 12300 68 26 6 12500 64 24 4 4 10 2 7 N N N N N N 
6. 5587 8/MC 15000 69 26 4 15400 65 22 3 3 12 3 7 N N N N N N 
7. 5569 12/FC 8000 56 39 5 8700 55 38 4 8 18 6 15 N N N N N N 
8. 5567 9/FC 7300 47 45 8 7600 45 43 3 5 10 3 9 N N N N N N 
9. 6096 4/FC 11400 30 61 9 11600 28 59 5 4 15 2 5 N N FEC  N N N 
10. 6204 10/FC 7200 53 40 4 7600 50 42 8 25 45 16 27 N N N N N N 
11. 7293 4/FC 12000 41 53 6 12300 40 52 4 4 12 3 9 N N N N N N 
12. 7341 5/MC 6200 46 45 9 7200 48 43 3 5 14 3 12 N N N N N N 
13. 7560 12/FC 15000 62 22 5 15300 53 23 4 4 12 2 5 N N N N N N 
14. 7479 8/MC 10700 66 26 8 10900 64 28 8 10 24 9 16 N N N N N N 
15. 8111 4/FC 14000 71 23 6 14200 65 24 1 5 12 3 9 N N N N N N 
16. 8291 7/MC 11000 61 34 5 11000 59 35 4 8 15 6 12 N N N N N N 
17. 8903 5/FC 12000 50 42 8 12100 52 44 5 7 16 5 10 N N N N N N 
18. 179 12/FC 10700 55 36 9 10800 55 41 4 5 15 3 9 N N N N N N 
19. 4172 5/FC 5600 60 33 7 7000 60 34 4 16 24 10 18 N N FP  N N N 
20. 4228 9/FC 8700 44 50 6 9200 55 41s 6 14 22 9 16 N N N N N N 
LABORATORY INVESTIGATION REPORT OF THE PATENTS 
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BT- Before Treatment, AT- After Treatment, N-Nil, TC-Total Blood Count, DC-Differential Blood Count,  P-Polymorphs, L-Leucocytes, E-
Eosinophils, ESR-Erythocyte Sedimentation Rate, mm-Milimeter, Hb-Hemoglobin, Alb-Albumin, Sug-Sugar, Dep-Deposits, FEC-Few 
Epithelial Cells, FP- Few pus cell    
S.No. OP.No. 
Age  / 
Sex 
Before Treatment After Treatment ESR (mm) Urine Analysis 
TC 
DC 
TC 
DC BT AT BT AT  
P% L%  E% P% L%  E% ½ Hr 1 Hr ½ Hr 1 Hr Alb Sug Dep Alb Sug Dep 
21. 5412 6/FC 16000 69 26 5 16200 65 32 3 4 15 3 10 N N N N N N 
22. 6626 8/FC 15200 65 30 5 15300 63 34 3 12 24 8 16 N N N N N N 
23. 7119 8/MC 8500 45 46 4 900 54 43 3 4 10 3 7 N N N N N N 
24. 12 8/FC 6700 51 40 9 8500 51 46 2 8 16 6 10 N N N N N N 
25. 9897 10/MC 8000 44 47 7 9500 55 41 4 2 8 2 2 N N N N N N 
26. 234 3/MC 9500 43 49 8 10000 49 47 4 7 15 6 12 N N N N N N 
27. 252 9/FC 6400 55 37 8 8000 60 36 4 7 15 6 12 N N N N N N 
28. 685 6/MC 19000 73 23 4 16000 62 26 3 12 22 8 14 N N N N N N 
29. 732 8/FC 5700 35 57 8 7500 44 51 4 8 18 6 16 N N N N N N 
30. 749 3/FC 7200 37 55 8 8500 38 57 5 22 40 18 20 N N N N N N 
31. 1178 3/MC 8000 40 53 7 9700 47 52 1 10 25 7 16 N N N N N N 
32. 2706 9/MC 7200 64 30 6 9000 66 26 8 5 12 3 9 N N N N N N 
33. 3470 8/MC 8000 41 50 9 9800 41 51 8 5 15 3 12 N N N N N N 
34. 3971 6/FC 10800 53 41 6 10600 55 41 6 12 20 7 15 N N N N N N 
35. 8470 7/MC 7400 61 33 6 8400 62 31 7 3 10 3 7 N N N N N N 
36. 9460 12/FC 7400 50 44 6 9000 52 46 2 7 15 4 13 N N N N N N 
37. 9889 11/MC 8300 46 45 9 9200 45 50 5 4 10 3 9 N N N N N N 
38. 3857 7/FC 8100 57 37 6 9700 558 37 5 7 15 5 11 N N N N N N 
39. 8616 5/FC 6700 35 58 7 8200 37 58 5 18 37 15 23 N N N  N N N 
40. 8681 4/MC 8300 46 45 6 9100 46 48 6 4 12 3 9 N N N N N N 
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BIO CHEMICAL AND HEMATOLOGICAL REPORTS  
 
S. 
No. 
OP.No. Name 
Age  / 
Sex 
Hb (gms/dl) 
RBC (million/ 
cu mm) 
PCV 
(%) 
MCV 
(fl) 
MCM 
(Pg) 
MCHC 
(gm/dl) 
PBS 
 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
1. 8512 Lokithashva 6/MC 8.2 8.6 3.4 3.6 36 34 80 92 26 31 32 35 HM NN 
2. 881 Harini 5/FC 9.6 11.2 3.5 3.8 32 34 72 83 28 32 26 29 HM NN 
3. 1024 Jayalakshmi 9/FC 10.6 12.1 3.1 3.3 34 34.2 76 80 26 38 32 33 HM NN 
4. 5230 Nishanthini 12/FC 8.5 8.9 3.5 3.8 21.5 24.5 73 86 23.2 26 27 32.5 HM HM 
5. 5251 Suganthan 6/MC 8.9 10.3 3.3 3.7 29.2 31.5 69.2 78.2 23.2 27 28.5 33 HM NN 
6. 5587 Sham Prabhakaran 8/MC 9.3 10.5 3.1 3.4 17 20 68 80 27 30 26 34 HM HM 
7. 5569 Jeevalakshmi 12/FC 10.4 12 3.2 3.8 21 23.2 75 85 27 32 31.2 33.5 HM NN 
8. 5567 Thamaraiselvi 9/FC 9.6 11.2 3.7 3.9 28.2 32 70 83 23.2 27 24.2 29 HM NN 
9. 6096 Lokshya 4/FC 10.3 12 3.4 3.6 32 34 71 87 22 29 32 34 HM NN 
10. 6204 Parameshwari  10/FC 9.6 11 4 4.2 28 30 74 83 26 28 32 34 HM NN 
11. 7293 Kaviya  4/FC 9.8 11.5 3.2 3.4 32 35 76 90 24 27 32 34.5 HM NN 
12. 7341 Naveen Shiva  5/MC 9.5 11.3 2.8 3.2 34 35.6 74 89 25 28 32 33.2 HM NN 
13. 7560 Yuvashree 12/FC 8.2 8.7 2.9 3.2 31 32.4 73 86 28 32 32 34.5 HM HM 
14. 7479 Tamil Selvan 8/MC 8.9 10.2 3.2 3.7 32 34 78 88 26 30 32 34 HM HM 
15. 8111 Kirthiga 4/FC 8.5 9 3.4 3.6 22 24 73 86 24.2 28 26.2 28.2 HM NN 
16. 8291 Joseph 7/MC 10.4 12.1 4 4.2 32 34 71 84 26 29 32 34.2 HM NN 
17. 8903 Sherlin 5/FC 10.3 11.9 3.2 3.3 26 28 71 82.5 28 30.2 26 30 HM NN 
18. 179 Shemirna 12/FC 10 11.8 3.2 3.4 32 36 76 90 22 27.3 34 35 HM NN 
19. 4172 Sakithi 5/FC 10.3 12.2 3.6 3.8 20.2 26 72 83 30 34 28.5 33 HM NN 
20. 4228 Merlin Jones 9/FC 9.6 12.2 3.6 3.6 20 27 68 82 28 32 31.5 34 HM NN 
BT- Before Treatment, AT- After Treatment, PCV-Packed Cell Volume, MCV-Mean Corpuscular Volume, RBC-Red Blood Cells  
MCH-Mean Corpuscular Hemoglobin, MCHC- Mean Corpuscular Hemoglobin Concentration, PBS-Peripheral Blood smear, HM-
Hypochromic Microcytic, NN-Normochromic Normocytic  
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S. 
No. 
OP.No. Name 
Age  / 
Sex 
Hb (gms/dl) 
RBC (million/ 
cu mm) 
PCV 
(%) 
MCV 
(fl) 
MCM 
(Pg) 
MCHC 
(gm/dl) 
PBS 
 
BT AT BT AT BT AT BT AT BT AT BT AT BT AT 
21. 5412 Pavithra 6/FC 8.7 9.1 3.5 3.8 26 34 71 83 28 29 27 29 HM NN 
22. 6626 Jayabharathi 8/FC 9.5 11.2 3.4 3.7 28 32 70 81 28 30.2 22 25 HM NN 
23. 7119 Hari Krishna 8/MC 9.7 11.3 3.9 3.9 23 28 73 88 23.2 27.5 27 30 HM NN 
24. 12 Soundarya 8/FC 9.6 11 3.5 3.8 27.5 32 63 77 25 29 28.5 31.5 HM NN 
25. 9897 Jagatheshkumar 10/MC 9.2 10.5 2.8 3.3 21.5 25 71 79 24 31.2 27.2 30.2 HM NN 
26. 234 Devakar 3/MC 9.6 10.8 3.5 3.9 20.2 24 70 80 30.2 33.2 29 32.5 HM NN 
27. 252 Hariba  9/FC 9.3 10.2 3.7 3.9 30 32 72 87 30 34 32 33 HM NN 
28. 685 Uthrapathi 6/MC 10.3 12.1 3 3.3 25.2 28 70 80 24.2 28.2 29.4 33 HM NN 
29. 732 Pooja 8/FC 9.4 10.3 3.5 3.9 21.4 27.2 52.8 60.5 28.3 31.4 23.7 27 HM NN 
30. 749 Lithisha 3/FC 9.5 11.1 3.3 3.5 22 28 73 86 24 30.2 28 32 HM NN 
31. 1178 Ariya 3/MC 8.5 9 3.1 3.3 22 28.2 70 83 26 30 29 31 HM HM 
32. 2706 Sham Sundar 9/MC 10.2 11.8 3.4 3.6 23.4 26.2 51.3 59.5 26.6 32 22.1 28.2 HM NN 
33. 3470 Nithilesh 8/MC 10.3 12 3.7 3.8 24.9 30 59.5 63.5 26.9 30.2 25.3 29.5 HM NN 
34. 3971 Thiyaammi 6/FC 10.6 12.1 3.4 3.5 28.6 31.5 62.9 77 25.4 31.2 20.5 25.2 HM NN 
35. 8470 Jaganan 7/MC 10.9 12.6 3.7 3.8 25.5 29.2 60.9 76 28.2 33 21.6 27.2 HM NN 
36. 9460 Sumaiya 12/FC 10.3 12 3.2 3.7 23.7 24.2 59.6 70.2 25.1 29.2 30.9 34 HM NN 
37. 9889 Harris Raj 11/MC 9.4 10.5 2.9 3.2 21.4 22.5 52.8 66.5 28.3 33.2 23.7 29.2 HM NN 
38. 3857 Anika  7/FC 10.3 11.8 3.2 3.4 34 35.2 53.4 69.2 21.4 25.4 30.6 34 HM NN 
39. 8616 Kaviya Shree 5/FC 10 11.7 3.5 3.8 21.5 26 72 80 24 26.2 27.2 35.2 HM NN 
40. 8681 Sai Tharun  4/MC 10.5 11.3 3.2 3.5 21.4 27 56.8 70.2 28.3 32.4 28.7 33.4 HM NN 
BT- Before Treatment, AT- After Treatment, PCV-Packed Cell Volume, MCV-Mean Corpuscular Volume, RBC-Red Blood Cells  
MCH-Mean Corpuscular Hemoglobin, MCHC- Mean Corpuscular Hemoglobin Concentration, PBS-Peripheral Blood smear, HM-
Hypochromic Microcytic, NN-Normochromic Normocytic  
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DISCUSSION 
Paandu Noi is a clinical entity described by Siddhars and having symptoms 
such as loss of appetite, lassititude, pallor of skin and mucous membrane, 
conjunctivae, tongue, and nail beds, dyspnoea on exertion. These symptoms are 
identical with Iron Deficiency Anaemia (Hypochromic microcytic anaemia) a 
clinical entity described in modern medical literature. 
 Iron deficiency anaemia is one of the most common and widespread 
nutritional disorder present throughout the world and its prevelance is higher in 
children.but they are not completely relieved from their symptoms by other system of 
medicine. Hence with the help of trial medicine from Siddha system, results and 
observation are noted for the study. 
The patients were examined based on Siddha as well as modern aspects. 
All the necessary investigation were made during the study. The results 
obtained from their studies were discussed below for better conclusion. 
Trial medicine administered was Chitramutti Nei – 4 – 5 ml, 2 times a day 
after food for 28 days.  
             In this study, 40 cases were selected according to the proforma with 
undergone investigation and treated with the trial drug Chitramutti Nei for 28days.  
The treatment investigation was done in the OPD of PG-Dept of Kuzhanthai 
Maruthuvam, Govt.Siddha Medical College attached to Arignar Anna Hospital of 
Indian Medicine Chennai-106, during the period 2015-2017. All the necessary 
investigations were carried out to all patients and trial drug were given. Daily follow 
up were done. All the patients were strictly advised to follow diet and peaceful 
lifestyle to normalize the immune mechanism. 
Drug Authetication : 
 All the ingredients of the trial drug Chitramutti Nei  were procured from 
indigenous drug shop, Park town, Chennai.  Freshly specimen of Sida cordifolia is 
collected from siddha medicinal plant garden, Mettur, Salem and root bark of 
Madhuca longifolia were collected from nativity and its organoleptic characters, 
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Microscopic and Macroscopic examination was conducted, identified  and 
authenticated by the concerned pharmacogononist,SCRI, Chennai. 
 
 
Pre clinical screenings: 
Biochemical Analysis: 
Qualitative Analysis of the trial drug revealed the presence of  iron, chloride, 
calcium, starch, reducing sugar. 
Phytochemical Analysis: 
The phytochemical analysis of the trial drug shows that the drug contains 
Glycosides, Carbohydrates, Coumarins, Phenols. 
Physico chemical Analysis: 
Loss on drying at 105c -  8.66% 
Total ash   - 2.11% 
P
H
    - 5 
Specific gravity  - 1.016 
Viscosity at 50c  - 11.5 
Refractive index  - 1.44 
Weight per ml   - 1.02 (gm/ml) 
Iodine value   - 120.65 mg/ml 
Saponification value  - 282.04 
Total Iron content  - 0.512 mg/ml 
Toxicity study of the drug:  
IAEC NO: SU/ CLTAR/ IAEC/ VII/ 042/ 2016 
ACUTE TOXICITY: 
               Acute and sub acute toxicity studies were conducted on experimental rats at 
Sathyabama University, Chennai, Tamilnadu. 
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               Acute toxicity study of the drug Chitramutti Nei was carried out as the 
OECD guideline-423 (Organisation to Econamic Co-operation and Development). 
                The acute toxicity study of  my trial drug was studied and the drug was 
proved safer for long term administration, as it did not exhibit any significant toxicity 
at 2000 mg / kg body weight.  
SUB ACUTE TOXICITY: 
                 Sub acute toxicity study as per the guideline of – 407. Under the dosage of 
trial drug 200mg / kg (Low dose), 400mg / kg (High dose) it did not exhibit any 
significant.  
HISTO PATHOLOGY: 
                 At the end of toxicity studies the animal were sacrified and they were 
subjected to hematological parameters (TC, DC & Hb) chemical parameters ( LFT, 
RFT) and histopathology of vital organs like Liver, Kidney, Spleen, Lungs were 
carried out. The studied did not exhibit the evidence of remarkable pathological 
lesions in the tissues. 
Pharmacological activity: 
 The pharmacological studies of trial medicine Chitramutti Nei showed 
significant Haematinic action Swiss albino rats. 
 Haematinic action of Chitramutti Nei was carried out by producing the by 
administrating a single intraperioneal injection of phenylhydrazine at a dose of 20 
mg/kg b.w. Drop out period of four days was awaited until the sufficient drop in Hb 
level was noticed in animals. Rats were considered as anaemic model if haemoglobin 
concentration was less than 14g/dl. Then the trial drug was administered show a 
potent haematinic action during the studies. 
 Anti helminthic activity was conducted in Indian adult earthworms 
(Pheretimaposthuma) were  collected from moist soil and washed with normal saline.  
Low dose and high dose treated group of which the worms were exposed to 10ml of 
the test formulation weight equivalent to 10gms and worms were exposed to 
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Albendazole 100mg/ml, 200mg/ml. The mean paralysis time and mean death time for 
each  dose was calculated. The result obtained from the present clearly indicates that 
the test drug CN has anti-helminthic property  
 The result of preclinical screening, the result of chemical analysis, 
Toxicological studies, Pharmacological studies were shown in anexures. 
Sex Distribution: 
 Among the 40 cases for this present study, 24 (60%) children were female and 
16 (40%) children were male. According to modern theory there is no apparent gender 
prediction.  
Age Distribution:  
Among the 40 cases, maximum numbers of patients 30% were in the age 
group of  3to 5 years, 20% were in the age group of 5 to 7 years, 35% were in the age 
group of 7 to 10 years and 15% were in the age group of 10 to 12 years. 
Socio Economic status: 
 Among the 40 cases, maximum numbers of patients 65% were in poor status, 
30% were in middle class and 5% were in rich class. The highest incidence was 
observed in poor class children due to low nutritional diet, so the poor children are 
more prone to the disease.  
Aetiological factor: 
Among 40 cases, 90% cases were due to worm infestation, 37.5% cases were 
due to nutrional deficiency because of poor intake of food respectively. 
Dietary Habits : 
Among 40 cases was reported, 90% belonged to mixed diet and 10% belonged 
to vegetarian diet habit respectively. 
According to Paruvakalam: 
Regarding Paruvakaalam among 40 cases, 2.5% cases were reported in Kaar 
kaalam, 5% cases were reported in Koothir kaalam and Elavenil Kaalam, 52.5% cases 
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were reported in Munpani kaalam, 35% cases were reported in Pinpani kaalam and 
no cases were reported in Muduvenil kaalam respectively 
Thinai: 
Among the 40 cases reported were from surroundings of Chennai which 
belongs to Neithal nilam.It cause increase in pitham 
Uyir Thathukkal: 
Disturbance of Vatham : 
 In 40 cases, among 10 types of Vaatham, Praanan was affected in a 100% of 
cases because of dyspnoea on exertion, Abanan was affected in a 65% of cases due to 
constipation, Viyaanan was affected in a 100% of cases because of pallor of skin, 
Samaanan and Kirukaran were affected in a 100% of cases due to loss of appetite, 
Devathathan was affected in a 100% of cases due to tiredness respectively. 
Disturbance of Pitham  
          Among 5 types of Pitham, except Aalosagam all types of pitham were affected. 
Sathagam was affected due to inability to do work, Ranjagam was affected which 
causes discolouration of blood, Anal pitham which causes loss of appetite, Prasagam 
was affected because of pallor of skin respectively. 
Disturbance of Kabam  
Among 40 cases, Aavalamgam was affected in 40 cases(100%) due to dyspnea 
and Kilathagam was affected in 40 cases (100%) due to loss of appetite respectively. 
UdalKattukal: 
In this, Saaram and Senneer were affected in 100% of the cases. Saaram was 
affected because of anorexia, Senneer was affected because of pallor of skin. 
Ennvagai Thervugal 
Among the Ennvagai thervukal, Naa, Niram and Vizhi were affected in all 
cases (100%). In 36 cases (90%) Malam, and in Naadi 20 cases (50%) Pithavaatham, 
in 9 cases (22.5%) vathakabam and in 12 cases (27.5%) Kabapitham were affected.               
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Nei kuri : 
Among 40 cases, Pitha neer was observed in 55% cases, vatha neer was 
observed in 20% cases, Kaba neer was observed in 25% cases. 
Clinical presentation: 
Out of 40 patients, before treatment all the 40 patients had 100% of pallor of 
conjunctivae, tongue, nail beds, Anorexia, fatigue, 65% of cases had constipation, 
50% of cases had Lack of interest and concentration, 100% of cases had dyspnoea on 
excertion, 43% of cases had weight loss. After treatment most of the patients were 
relieved from the symptoms of anorexia and constipation. Pallor of conjunctivae, 
tongue, nail buds was present in 25%, fatigue in 10%, lack of interest and dyspnoea 
on excertion  in 15%, weight loss in 5% were observed in this study. 
Lab investigation: 
 Routine blood and urine examination were done before and after the treatment. 
In most of the cases, Total RBC count, PCV, MCV, MCH, MCHC were observed to 
be reduced. After treatment there is a tremendous increase in the haemoglobin level, 
Total RBC count, PCV,MCV,MCH, MCHC. 
 Haemoglobin range was Good (65%) in 24 cases, Moderate (25%) in 10 cases, 
Poor (15%) in 6 cases in prognosis. 
Bio statistical study:  
Since the p value is significant in all signs and symptoms . So there is 
significant reducing of signs & symptoms among the patients for the treatment of 
Paandu Noi. Hence it is concluded that the treatment was effective and significant. 
Result observed from haemoglobin level: 
Since the P value is highly significant (<0.001), So the treatment was 
significantly improving the Hb level among the patients for the treatment of Paandu 
Noi.  
Results  
The outcome of this study showed encouraging results. Among the 40 patients 
good improvement observed in 65%, moderate improvement in 25% and mild 
improvement in 15% and no adverse events observed clinically during the course of 
treatment. 
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Treatment: 
In this study all 40 cases were treated with Chitramutti Nei. The trial medicine 
having the properties of neutralizing pitham was given to the patients to set right the 
deranged pitham on the basis of Arusuvai and Pancha bootham. 
So the selected trial drug is in the form of ghee, is found to be normalize the 
increased pitham. Intake of ghee in therapeutic doses increase appetite and gives relief 
from abdominal discomfort and constipation. 
The Rationale behind the use of trial drug as a ghee: 
The lipid soluble drugs are rapidly distributed throughout the intra and 
extracellular spaces. That is drug given in the form of Ghee which is a fat are rapidly 
absorbed from the gut because of their lipid solubility are known to readily diffuse 
into the CSF and the brain. 
The main reason behind this is, it cross Blood Brain Barrier. This membrane 
separating the CNS tissue and the circulating blood is lipophilic in nature. Thus it 
selectively allows the passage of lipids and lipid soluble across it.  
The trial medicine contain iron in the form of ferrous state that are easily 
absorbed. And also contain Vitamin C it enhances the absorption of iron. The efficacy 
was established throughout the treatment. During the treatment the study subject were 
strictly advised to have Iron rich diet. 
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                                         SUMMARY 
To study the efficacy of Siddha trail drug Chitramutti Nei as internal medicine 
for the treatment of Paandu Noi in children.This disease mostly resembles Iron 
deficiency anaemia in modern system. Literature evidences of both Siddha and 
Modern system were collected and also the ingredients of the trial drug was reviewed 
as well. For the clinical study, 40 patients were selected based on protocol. This study 
is conducted after the drug being screened by the Screening committee and approved 
by the Institutional Ethical Committee (IEC) of Govt siddha medical college Chennai. 
Selected patients with Paandu Noi diagnosed clinically treated in outpatient 
department of Govt siddha medical college attached with Arignar Anna Hospital of 
Indian Medicine, Chennai-106. They were undergone laboratory investigation treated 
with trial drug, observed for clinical improvement and any adverse reaction. 
Qualitative analysis of the Chitramutti Nei presence of  iron, calcium, starch, 
chloride and Reducing sugar. Phytochemical analysis of the trial drug shows that 
presence of Glycosides, carbohydrates, coumarins, phenol.  
Physico chemical analysis of the trail drug shows the PH 5, Total ash value 
2.11%, Moisture: 8.66% shows the safe and effectiveness of the trial drug . In 
elemental analysis shows that one milliliter of  Chitramutti Nei contain 0.512(mg/ml) 
of iron. 
Toxicological studies shows that, it has no significant toxic effect. From the 
preclinical pharmacological study shows that the drug has got a significant haematinic 
activity and Antihelminthic activity.   
Bio – statistically analysis of the clinical trial reveals significant p values  
0.05 and  0.01 and concluded that the treatment is effective and significant. 
Among the 40 patient‟s good improvement was observed in 24 cases (65%), 
moderate improvement in 10 cases (25%) and mild improvement in 6 cases (15%). 
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CONCLUSION 
Paandu noi is mainly caused by the derangement of Pitham  followed by 
vatham and kabam. The deranged kuttram is settled down by the kaippu  suvai in the 
trial drug there by medicine act effective in cure the disease. 
In physico chemical Analysis iron was found to be present as effective 
ingredients in treating anaemia. 
The Chitramutti Nei reveal no toxicity in the pre clinical studies and hence 
proven to be safe for human administration. 
From the pre- clinical pharmacological study it is evident that the trial 
medicine has significant Haematinic action and Antihelminthic action. 
Also Chitramutti Nei has been proved clinically. Since as it raises the 
haemoglobin level in a marked level to the patients given regularly for not less than 
30 days along with supplementary diets. Both symptomatic and qualitative 
improvement were absorbed. For prognosis, routine haematological investigation was 
taken. During the treatment no adverse events were observed. 
Statistically it has been proved that it shows significant raise in the 
haemoglobin level. 
Hence I concluded that the trial drug Chitramutti Nei will be a better drug that 
can be used in the treatment of Paandu Noi. 
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ANNEXURE -II 
BIO-CHEMICAL ANALYSIS 
PREPARATION OF EXTRACT: 
2 gm of the Chitramutti Nei is taken in a 100 ml beaker and 20 ml of distilled water is 
added. The solution is boiled for 10 minutes, cooled and then filtered. The filtrate is 
called extract. This fluid is taken for the Bio- Chemical analysis 
QUALITATIVE ANALYSIS 
S.NO EXPERIMENT OBSERVATION INFERENCE 
 I. TEST FOR ACID RADICALS   
1.  Test for Chloride 
2 ml of extract is added with dilute nitric 
acid till the effervescence ceases. Then 2 ml 
of silver nitrate solution is added 
Presence  of white 
precipitate 
Present 
2.  Test for Phosphate: 
2 ml of the extract is treated with 2ml of 
Ammonium molybdate solution and 2 ml of 
concentrated nitric acid 
Absence of yellow 
precipitate 
Absent 
3.  Test for Carbonate: 
 2 ml of the extract is treated with 2 ml of 
magnesium sulphate solution  
Absence of white 
precipitate 
Absent 
4.  Test for Sulphide: 
1 gm of the substance is treated with 2 ml of 
concentrated Hydrochloric acid 
Absence of Rotten 
egg smelling 
Absent 
5.  Test for Sulphate: 
2ml of the above prepared extract is taken in 
a test tube to this added 2ml of 4% 
ammonium oxalate solution 
Absence of white 
precipitate.  
Absent 
6.  Test for Nitrate 
1 gm of the substance is heated with copper 
turnings and concentrated sulphuric acid and 
viewed the test tube vertically down 
Absence of reddish 
brown gas  
Absent 
7.  Test for Nitrite 
 3 drops of the extract is placed on a filter 
paper. On that, 2 drop of Acetic acid and 2 
drops of Benzidine solution is placed 
Absence of 
yellowish red 
colour 
Absent 
8.  Test for Borate 
2 pinches of the substance is made into paste 
by using Sulphuric acid and Alcohol (95%) 
and introduced into the blue flame 
Absence of Green 
tinged flame 
Absent 
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  II TEST FOR BASIC RADICALS   
9.  Test for copper 
 One pinch of the substance is made 
into paste with concentrated 
Hydrochloric acid in a watch glass and 
introduced into the Non luminous part 
of the flame 
Absence of Bluish 
green coloured 
flame 
Absent 
10.  Test for  iron 
 To the 2 ml of extract, 2 ml of 
Ammonium thiocyanate solution is 
added. 
Presence of blood 
red colour 
Present 
11.  Test for zinc 
To the 2 ml of extract Sodium 
hydroxide solution is added in drops 
to excess 
Absence of white 
precipitate 
Absent 
12.  Test for calcium 
2 ml of the extract is added with 2 ml 
of 4 % Ammonium oxalate solution.  
Presence of white 
precipitate 
Present 
13.  Test for magnesium  
2ml of extract sodium hydroxide 
solution is added in drops to excess 
Absence of white 
precipitate 
Absent 
14.  Test for potassium 
A pinch of  substance is treated with 2 
ml of sodium nitrite solution and then 
treated with 2 ml of Cobalt nitrate in 
30% glacial Acetic acid 
Absence of yellow 
precipitate 
Absent 
15.  Test for sodium 
2 pinches of the substance is made 
into paste by using Hydrochloric acid 
and introduced into the blue flame 
Absence of yellow 
colour flame 
Absent 
16.  Test for starch  
 2 ml of extract is treated with weak 
iodine solution  
 Blue colour is 
obtained  
Present 
17.  Test for reducing sugar 
 5 ml of Benedict‟s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
added 10 drops of the extract and 
again boiled for 2 minutes. The colour 
changes are noted 
Green colour is 
obtained 
Present 
18.  Test for tannic acid 
The extract is treated with ferric 
chloride solution 
Absence of Blue 
black precipitate  
Absent 
19.  Test of the alkaloids 
2 ml of the extract is treated with 2 ml 
of  Picric acid 
 Yellow colour is 
not developed 
Absent 
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RESULTS: 
The trial drug Chitramutti Nei contains  
Acid radical: 
Chloride 
Basic radicals:  
Iron, calcium, starch and Reducing sugar. 
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ANNEXURE - III 
PHYSICOCHEMICAL EVALUATION 
Project ID  : NRS/AS/0018/01/2017  
Institute  : Govt Siddha Medical College, Chennai 
Sample Name  :Chitramutti Nei 
Sample ID   : CN 
Percentage Loss on Drying: 
10gm of test drug was accurately weighed in evaporating dish .The sample 
was dried at 105
o
C for 5 hours and then weighed. 
             Percentage loss in drying = Loss of weight of sample/ Wt of the sample X 
100 
Determination of Total Ash: 
3 g of test drug was accurately weighed in silica dish and incinerated at the 
furnace a temperature 400 ºC until it turns white in color which indicates absence of 
carbon. Percentage of total ash will be calculated with reference to the weight of air-
dried drug. 
                    Total Ash = Weight of Ash/Wt of the Crude drug taken X 100 
Determination of pH: 
Sample being oily in nature the direct litmus evaluation method was adopted 
to check the pH of the sample.  
Determination of specific gravity:  
Fill the dry sp. gravity bottle with prepared samples in such a manner to 
prevent entrapment of air bubbles after removing the cap of side arm. Insert the 
stopper, immerse in water bath at 50
O
C and hold for 30 min.  Carefully wipe off any 
oil that has come out of the capillary opening. Remove the bottle from the bath, clean 
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and dry it thoroughly. Remove the cap of the side and quickly weigh. Calculate the 
weight difference between the sample and reference standard. 
Determination of Iodine value : 
About 20 gm of oil was transferred into Iodine flask. To which 10 ml of 
chloroform  was added and warmed slightly and cooled for 10 minutes. Followed by 
this about 25 ml of Wiji‟s solution was added in the same flask and shaken well. The 
flask was allowed to stand for 30 mins and refrigerated for anhour.T About 10 ml of 
KI solution was added to this and titrated against 0.1 N Sodium thiosulphate solutions 
until the appearance of yellow colour. 1 ml of starch indicator was added and again 
titrated against the sodium thiosulphate solution from the burette. Disappearance of 
blue colour indicates end point. Repeat the above procedure without taking sample 
and note the corresponding reading for blank titration. 
Determination of saponification value : 
About 2 gm of test sample was transferred into the round bottomed flask. To 
this about 20 ml of 0.5 N alcoholic KOH solutions was added to the round bottomed 
flask. Repeatthe same procedure with out taking the sample for blank titration . 
Reflux both sample and blank round bottomed flasks for 1 hour. After reflux, allow 
both the round bottomed flasks to cool. Titrate the samples using 0.5 N HCl with 
phenolphthalein indicator. The disappearance of pink indicates the end point.  
FINAL TEST REPORT: 
 
Parameter Observation 
Color Dark Yellowish  
Smell Pleasant 
Touch Greasy 
Appearance Clear After Melting 
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S.No Parameter Mean (n=3) SD 
1.  Loss on Drying at 105 °C (%) 8.66 ± 1.22 
2.  Total Ash (%)  2.11 ± 0.50 
3
. 
pH  5 
 
S.No Specific Test Chitramutti Nei 
1.  Specific Gravity 1.016 
2.  Viscosity at 50oC (Pa s) 11.55  
3.  Refractive index  1.44 
4.  Weight per ml (gm/ml) 1.02  
5.  Iodoine value (mg I2/g) 120.65 
6.  Saponification Value  
(mg of KOH to saponify 1gm of 
fat) 
282.04 
7.  Total Iron content (mg/ml) 0.512  
 
ESTIMATION OF IRON: 
Preparation of standard solution: 
  0.2g of ferric ammonium sulphate was dissolved in distilled water containing 
10ml of concentrated hydrochloric acid and the volume was made up to 250ml with 
distilled water 3. From this stock solution 1, 2, 3, 4 & 5ml was pipette out into 5 
different 50ml volumetric flask and 5ml of 10% aq. hydroxyl ammonium chloride 
solution was added and the pH was adjusted between 3 to 5 using 2M sodium acetate 
buffer solution and 4ml of 1, 10-phenanthrolin was added and finally the volume was 
made up to 50ml with distilled water. After 15-20 min. the absorbance was noted at 
515nm. The standard curve of concentration Vs absorbance was plotted. 
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Preparation of Test Solution: 
   0.21g of test sample was taken with 50ml of 6N hydrochloric acid and boiled for 2-
3 min. Then it was filtered and the volume was made up to 250ml with distilled water. 
From this 5ml of solution was pipette out into 50ml volumetric flask and the same 
procedure was followed as in the preparation of standard solution. After 15-20 min. 
the absorbance was noted at 515nm. From the absorbance the corresponding 
concentration was determined by extrapolation of calibration curve. 
 
 
 
 
 
 
  Unknown concentration 0.512 mg/ml. 
Result : 
Total iron content  -0.512mg/ml. 
  
Concentration mg/ml Absorbance 
0.1 0.321 
0.2 0.448 
0.3 0.583 
0.4 0.725 
                 0.5 0.938 
Test Sample 0.924 
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PHYTOCHEMICAL ANALYSIS 
 
Sample Preparation 
Chitramutti Nei (CN) was extracted with hexane and the extract was subjected 
to the following analysis 
1) Test for alkaloids: 
Mayer's Test: To the extract, 2ml of mayer's reagent was added, a dull white 
precipitate revealed the presence of alkaloids. 
 
2)  Test for coumarins:  
To 1 ml of extract, 1 ml of 10% sodium hydroxide was added. The presence of 
coumarins is           indicated by the formation of yellow color. 
3) Test for saponins:  
To 1 ml of the extract, 5 ml of water was added and the tube was shaken 
vigorously. Copious lather formation indicates the presence of Saponins. 
4) Test for tannins:  
To the extract, ferric chloride was added, formation of a dark blue or greenish 
black color showed the presence of tannins. 
5) Test for glycosides- Borntrager‟s Test 
Test drug is hydrolysed with concentrated hydrochloric acid for 2 hours on a 
water bath, filtered and the hydrolysate is subjected to the following tests. To 2 
ml of filtered hydrolysate, 3 ml of choloroform is added and shaken, choloroform 
layer is separated and 10% ammomia solution is added to it. Pink colour indicates 
presence of glycosides. 
6) Test for flavonoids: 
To 0.1ml of the test sample about 5 ml of dilute ammonia solution were been 
added followed by addition of few drops of conc. Sulfuric acid. Appearance of 
yellow color indicates the presence of Flavonoids. 
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7) Test for phenols: 
Lead acetate test: The extract was taken; 3 ml of 10% lead acetate solution was 
added.  A bulky white precipitate indicated the presence of phenolic compounds. 
8) Test for cardial glycosides: 
Keller-Killani Test: Plant extract treated with 2 ml glacial acetic acid containing 
a drop of         FeCl3 .A brown colour ring indicates the presence of positive test. 
9) Test for steroids: 
To the test solution 2ml of chloroform was added with few drops of conc. 
Sulphuric acid (3ml), and shaken well. The upper layer in the test tube was turns 
into red and sulphuric acid layer showed yellow with green fluorescence. It 
showed the presence of steroids. 
10) Test for Quinones:  
The extracts were treated separately with Alc. KOH solution. Appearance of 
colors ranging from red to blue indicates the presence of Quinones. 
11) Test for Cyanins 
A. Aanthocyanin: 
To 2 ml of the leaf extract, 1 ml of 2N sodium hydroxide was added and heated 
for 5 min at 100 Cᵒ. Formation of bluish green colour indicates the presence of 
anthocyanin. 
B. Betacyanin: 
To 2 ml of the leaf extract, 1 ml of 2N sodium hydroxide was added and heated 
for 5 min at 100 Cᵒ.  Formation of yellow colour indicates the presence of 
betacyanin. 
12) Test for Carbohydrates - Benedict‟s test 
To 0.5 ml of test drug about 0.5 ml of Benedic‟s reagent is added. The mixture 
is heated on a boiling water bath for 2 minutes. A characteristic coloured 
precipitate indicates the presence of sugar. 
13) Test for terpenoids: 
Salkowski test: 5ml of extract was mixed in 2ml of chloroform, and concentrated 
sulphuric acid was carefully added to form a layer.  A reddish brown colouration 
of the interface indicates the presence of terpenoids. 
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RESULT ANALYSIS 
 
PHYTOCOMPONENTS CN 
ALKALOIDS - 
FLAVONOIDS - 
GLYCOSIDES + 
STEROIDS - 
CARBOHYDRATES + 
TRITEREPNOIDS - 
COUMARINS + 
PHENOLS + 
CARDIAC GLYCOSIDES - 
TANNINS - 
SAPONINS - 
PROTEINS - 
ANTHOCYANIN - 
BETACYANIN - 
QUINONES - 
 
+   Indicates positive 
- Indicates Negative 
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STERILITY TEST BY POUR PLATE METHOD 
Objective:  
The pour plate techniques were adopted to determine the sterility of the product. 
Contaminated / un sterile sample (formulation) when come in contact with the 
nutrition rich medium it promotes the growth of the organism and after stipulated 
period of incubation the growth of the organism was identified by characteristic 
pattern of colonies. The colonies are referred to as Colony Forming Units (CFUs).   
Methodology: 
About 1ml of the test sample was inoculated in sterile petri dish to which about 15 mL 
of molten agar 45
o
C were added. Agar and sample were mixed thoroughly by tilting 
and swirling the dish. Agar was allowed to completely gel without disturbing it. 
(about 10 minutes). Plates were then inverted and incubated at 37
o
 C for 24-48 hours. 
Grown colonies of organism was then counted and calculated for CFU. 
 
 
 
 
Observation 
No growth was observed after incubation period. Reveals the absence of specific 
pathogen 
Result 
No growth / colonies were observed in any of the plates inoculates with the test 
sample. 
Test Specification Result Method 
E-coli Absent Absent As per AYUSH 
specification 
Salmonella Absent Absent 
Staphylococcus Aureus Absent Absent 
Pseudomonas Aeruginosa Absent Absent 
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     ANNEXURE-IV 
PROJECT REPORT ON  
TOXICITY PROFILING OF CHITRAMUTTI NEI 
 
 
Name Dr.G.G.KALAISELVI 
IAEC SU/CLATR/IAEC/VII/043/2016 
Name of the 
Formulation Chitramutti Nei 
Abbreviation CN 
 
ACUTE TOXICITY STUDY 
Acute toxicity study of the study drug Chitramutti Nei was carried out as per 
OECD guideline (Organization for Economic Co-operation and Development) 
Guideline-423. 
Animal 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
0 
Cand relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
Acute toxicity Study 
Acute toxicity study will be carried out in accordance with OECD guideline 
423 
1
. The animals were fasted overnight with free access to water. The study was 
conducted with single oral dose administration of Chitramutti Nei.  
IAEC SU/CLATR/IAEC/VII/042/2016 
 
 
Animal Grouping 
One group consist of 6 female rats were used for this study. The dose utilized 
for evaluation of acute toxicity study is about 2000 mg/kg higher than that of the 
therapeutic dose.  
Dose Equivalent = 1ml is equivalent to 1.02085 gm 
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Animal Grouping 
GROUP I : Animals received Test drug 2000 mg/kg (p.o)  
The animals were fasted overnight (12- 16 hrs) with free access to water. The 
study was conducted with single oral administration of study drug Chitramutti Nei 
2000mg/kg equivalent to 0.4ml (p.o). The animals were observed continuously for 
first 72 h and then 14 days for emerging signs of behavioral changes, body weight 
changes and for mortality. 
Occurrence of toxicity in animals were observed continuously for the first 4 to 
24 h and observed periodically for the next 14 days.  Observation includes the change 
in skin, fur, eyes and mucus membrane. Appearance of C.N.S,C.V.S and A.N.S related 
toxicity such as tremors, convulsions, sedation, steric behavior, respiratory distress, 
cardiovascular collapse, response to sensory stimuli, salivation, diarrhea, lethargy, 
sleep, coma and mortality were observed with special attention. 
Body weight was recorded periodically. At the end of the experiment all 
animals were subjected for gross necropsy and observed for pathological changes. 
SUB-ACUTE TOXICITY STUDY 
Sub-acute toxicity study was carried out as per OECD guidelines Guideline-
407 
2
. 
Animals 
Healthy adult Wistar albino rat weighing between 170-200 g were used for the 
study.  The animals were housed in poly propylene cages and were kept in well 
ventilated with 100% fresh air by air handling unit (AHU). A 12 light / dark cycle 
were maintained .Room temperature was maintained between 22 + 2
o 
Cand relative 
humidity 50–65%. They were provided with food (Sai feeds, Bangalore, India) and 
water ad libitum. All the animals were acclimatized to the laboratory for 7 days prior 
to the start of the study. 
The experimental protocol was approved by The Institutional Animal Ethics 
Committee of Sathyabama University, Chennai, Tamil Nadu, India. 
Animal Grouping 
Animals were divided into three groups of 06 animals each consist of 3 male 
and 3 female rats. 
GROUP I : Animals received saline 5 ml/kg b.w (p.o)             
GROUP II : Animals received low dose of test drug 200 mg/kg (p.o) 
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GROUP III : Animals received high dose of test drug 400 mg/kg (p.o) 
The animals were randomly divided into control group and drug treated 
groups for two different doses viz. low dose (200 mg/kg b.w) equivalent to 0.2 ml and 
high dose (400 mg/kg b.w) equivalent to 0.4 ml,p.o per rat. 
The animals were administrated with the study drug once daily for 28 days. 
The animals in group I (control group) received normal saline 5 ml/kg b.w. The 
animals in group II received low dose of Chitramutti Nei 200 mg/kg b.w (p.o) and 
group III received high dose of Chitramutti Nei 400 mg/kg b.w (p.o). 
The rats were weighed periodically and observed for signs of toxicity pertain 
to C.N.S, C.V.S, A.N.S including behavioral changes, food - water intake and 
morphological changes. At the end of 28
th
 day, the animals were fasted for overnight 
with free access to water. On 29
th
 day the animals were sacrificed with excess 
anesthesia. Blood samples were collected from aorta and stored in EDTA 
(ethylenediamine –tetra actate) for Hematological analysis and for serum generation 
for biochemical analysis. 
The vital organs including heart, brain, lungs, spleen, kidneys, liver, stomach, 
testes, and ovary were harvested and carefully examined for gross lesions. The organs 
were preserved in 10% formalin for histopathological assessment and interpretation. 
Hematological analysis 
Blood samples were analyzed using established procedures and automated 
Bayer Hematology analyzer. Parameters evaluated include Packed Cell Volume 
(PCV), Red Blood Cells (RBC) count, White blood cell count (WBC), Platelet Count, 
Hemoglobin (Hb), Mean cell Haemoglobin Concentration (MCHC), Mean Red Cell 
Volume (MCV), Mean Cell Hemoglobin (MCH), Mean platelet volume (MPV), 
Neutrophils, Eosinophil‟s, Basophils, Lymphocytes and Monocytes.  
Biochemical analysis 
3
 
Serum samples were analyzed for High Density Lipoprotein (HDL), Low 
density Lipoprotein (LDL) , Very low density Lipoprotein (VLDL) , Triglycerides 
(TGL), Total Cholesterol , Blood urea nitrogen (BUN), Creatinine, Albumin, Total 
Protein, Glucose, Uric acid, Aspartate Transaminase (AST), Alanine amino 
Transaminase (ALT) and Alkaline  Phosphatase (ALP) using Mind ray auto analyzer 
model BS 120. 
Histopathological evaluation 
4
 
 Organs included of heart, brain, lungs, spleen, kidneys, liver, stomach, testes 
and ovary. Histological slides of organs were made and observed under the 
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microscope.  The pathological observations of cross section of these organs were 
performed on gross and microscopic bases. Histological examinations were performed 
on the preserved tissues with particular emphasis on those which showed gross 
pathological changes. 
Statistical analysis 
The statistical analysis was carried by one way ANOVA (GRAPH PAD 
PRISM 5 computer program). Results were expressed as mean ± standard error .A 
statistical comparison was carried out using the Dunnet‟s test for the control and 
treatment group. 
 
Fecal Pellet Analysis 
Methodology 
Rats of control and treatment group were allowed to explore to open field on clean 
and sterile Stainless steel tray. The collected pellets were analyzed for consistency, 
color, Shape, Presence of blood cells etc 
                                                                                            Acute Toxicity Study 
 
Sub-Acute Toxicity Study 
Analysis Group I Group II 
Group 
III 
Consisteny Soft Soft 
Soft -
steatorrh
ea 
Shape 
Oblong 
 
Round 
ended 
Round 
ended 
Colour Greenish 
Brown Brown 
Mucous 
Shedding Absence Absence Absence 
Blood 
Cells Absent Absent Absent 
Signs of 
Infection 
None 
Observed 
None 
Observed 
None 
Observed 
 
Muscle Grip Strength Analysis 
The grip strength test is a simple non-invasive method designed to evaluate rat muscle 
force in vivo. Rats of control and drug treated group was allowed to hold the pull bar 
with both the hind limbs firmly then the animal was gently pulled back with the tail 
until the animal lost the grip toward the bar. The procedure was repeated to get the 
Analysis Group I 
Consistency 
Soft- 
Fatty 
Shape Oblong 
Colour 
Dark 
Green 
Mucous 
Shedding Absence 
Blood Cells Absent 
Signs  
 
of Infection 
None 
Observed 
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average value. Muscle grip ness of the drug treated group was compared to that of the 
control rat to ensure the change in coordination.  
Metabolic Cage for Urine Collection 
Rat of control and treatment group was placed individually in metabolic cage with 
free access to feed and water. Urine dropping from the animal was collected using 
specialized wire mesh system fixed at the base of the cage having provision to trap the 
fecal pellet mixed with urine sample. The collected urine sample was subjected to 
analysis with respect to colour, pH, glucose, ketone bodies, pus and blood cells. 
RESULTS 
Assessment of clinical signs in rats treated with Chitramutti Neion Acute toxicity 
study 
Acute 
Parameter Group I 
Clinical Signs Parameters for the 
duration of 14 days Test Drug 2000mg/kg 
Number of animals observed 6 Female  
Lacrimation Absence 
Salivation Absence 
Animal appearance Normal 
Tonic Movement Absence 
Clonic Movement Absence 
Laxative action Mild 
Touch Response Normal 
Response to Sound Normal Response 
Response to Light Normal Response 
Mobility Normal Response 
Respiratory Distress Nil 
Skin Color Normal 
Stereotype behavior Absence 
Piloerection Absence 
Limb Paralysis Absence 
Posture Normal 
Open field behavior Normal 
Giat Balancing Normal 
Freezing Behaviour Absent 
Sings of Stress and Anxiety None Observed 
Muscular coordination Normal 
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Muscle grip Normal 
Sedation Absence 
Social Behavior Normal 
Urine Analysis No Abnormality 
Urine Colour Yellowish 
Urine Ph 6 
Urine -Glucose                         Absence 
Urine -Ketones                        Absence 
Urine- Bilirubin                         Absence 
Urine-Blood  Cells       Negative 
Urine - Pus cells Negative 
Mortality Nil 
 
Quantitative data on the body weight of rats treated with Chitramutti Nei in 
Acute toxicity study 
Group I Before Treatment Weight in Gms 
After Treatment  
Weight in Gms 
Mean 
177.7 186.2 
Std. Deviation 
6.89 9.847 
Std. Error 
2.813 4.02 
Values are mean ± S.D (n = 6 per group). Statistical significance carried out using one 
way ANOVA followed by Dunnett‟s test. 
Assessment of clinical signs in rats treated with Chitramutti Nei on Sub-Acute 
toxicity study 
SUB ACUTE 
Parameter Group I Group II Group III 
Clinical Signs 
Parameters for the 
duration of 28 days Control 
Test Drug 
200mg/kg 
Test Drug 
400mg/kg 
Number of animals 
observed 
3 Males and 
3Females  
3 Males and 
3Females  
3 Males and 
3Females  
Lacrimation Absence Absence Absence 
Salivation Absence Absence Absence 
Animal appearance Normal Normal Normal 
Tonic Movement Absence Absence Absence 
Clonic Movement Absence Absence Absence 
Laxative action Absence Mild Moderate 
Touch Response Normal Normal Normal 
Response to Sound 
Normal 
Response 
Normal 
Response 
Normal 
Response 
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Response to Light 
Normal 
Response 
Normal 
Response 
Normal 
Response 
Mobility 
Normal 
Response 
Normal 
Response 
Normal 
Response 
Respiratory Distress Nil Nil Nil 
Skin Color Normal Normal Normal 
Stereotype behavior Absence Absence Absence 
Piloerection Absence Absence Absence 
Limb Paralysis Absence Absence Absence 
Posture Normal Normal Normal 
Open field behavior Normal Normal Normal 
Giat Balancing Normal Normal Normal 
Freezing Behaviour Absent Absent Absent 
Sings of Stress and 
Anxiety None Observed None Observed None Observed 
Muscular coordination Normal Normal Normal 
Muscle grip Normal Normal Normal 
Sedation Absence Absence Absence 
Social Behavior Normal Normal Normal 
Urine Analysis No Abnormality No Abnormality No Abnormality 
Urine Colour Yellowish Yellowish Yellowish 
Urine pH 6 7 7 
Urine -
Glucose                         Absence Absence Absence 
Urine -
Ketones                        Absence Absence Absence 
Urine- 
Bilirubin                         Absence Absence Absence 
Urine-Blood  Cells       Negative Negative Negative 
Urine - Pus cells Negative Negative Negative 
Mortality Nil Nil Nil 
 
Effect of Chitramutti Neion Body weight of Rats in Sub-acute toxicity study 
Group I 
Before Treatment Weight in 
Gms 
After Treatment Weight in 
Gms 
Mean 
184 195.5 
Std. Deviation 
5.177 5.958 
Std. Error 
2.113 2.432 
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Group II 
Before Treatment Weight in 
Gms 
After Treatment Weight in 
Gms 
Mean 
180.5 191.2 
Std. Deviation 
7.893 10.44 
Std. Error 
3.222 4.262 
Group III Before Treatment 
After Treatment Weight in 
Gms 
Mean 
184.3 194.2 
Std. Deviation 
6.563 6.735 
Std. Error 
2.679 2.75 
 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett‟s test. 
Quantitative data on the food and water intake of rats treated with Chitramutti 
Nei for 28 days in Sub-acute toxicity study 
GROUP I Food intake Water intake 
Mean 17.42 22.25 
Std. Deviation 3.573 6.437 
Std. Error 1.787 3.219 
GROUP II Food intake Water intake 
Mean 19.25 32.83 
Std. Deviation 1.032 2.253 
Std. Error 0.5159 1.126 
GROUP III Food intake Water intake 
Mean 16.75 31 
Std. Deviation 1.813 2.126 
Std. Error 0.9065 1.063 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett‟s test. 
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Effect of Chitramutti Nei on Haematology profile of rats in sub-acute toxicity 
study. 
GROUP I 
WBC 
count 
(×10 
3
 
µl) 
RBC                  
(×10 
6
 
µl) 
PLT                  
(×10 
3
 
µl) 
MCV                       
(fl) 
MCH                
(pg) 
MCHC          
(g/dl) 
HGB         
(g/dl) 
Mean 9.933 6.6 679.8 58.83 19.22 32.75 13.27 
Std. Deviation 1.483 1.103 174.3 6.218 2.232 1.299 1.089 
Std. Error 0.6053 0.4502 71.15 2.538 0.9112 0.5303 0.4447 
GROUP II 
 WBC 
count 
(×10 
3
µl) 
RBC                  
(×10 
6
 
µl) 
PLT                  
(×10 
3
 
µl) 
MCV                       
(fl) 
MCH                
(pg) 
MCHC          
(g/dl) 
HGB         
(g/dl) 
Mean 8.85 6.517 1008 62.48 19.57 31.57 13.05 
Std. Deviation 0.8939 0.9196 244.9 5.319 1.99 1.372 1.495 
Std. Error 0.3649 0.3754 100 2.172 0.8123 0.5602 0.6103 
GROUP III 
 WBC 
count 
(×10
3
 
µl) 
RBC                  
(×10 
6
 
µl) 
PLT                  
(×10 
3
 
µl) 
MCV                       
(fl) 
MCH                
(pg) 
MCHC          
(g/dl) 
HGB         
(g/dl) 
Mean 8.95 6.183 1015 62.25 18.07 32.77 13.9 
Std. Deviation 2.651 1.026 224.8 4.567 1.802 1.581 1.556 
Std. Error 1.082 0.4191 91.76 1.864 0.7356 0.6453 0.6351 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett‟s test. 
Effect of Chitramutti Nei onHaematology profile of rats in sub-acute toxicity 
study. 
GROUP I 
Lymph        
(%) 
Mon            
(%) 
Neutrophils   
10
3
/mm3 
Eosinophils 
(%) 
Basophils 
(%) 
MPV     
(fl) 
Mean 80.92 3.6 2.5 1.667 0.1667 5.833 
Std. Deviation 6.151 0.9033 0.6033 0.2251 0.4082 1.14 
Std. Error 2.511 0.3688 0.2463 0.09189 0.1667 0.4652 
GROUP II 
Lymph        
(%) 
Mon            
(%) 
Neutrophils   
10
3
/mm3 Eosinophils 
(%) 
Basophils 
(%) 
MPV     
(fl) 
Mean 76.93 3.45 2.15 1.55 0.1667 6.167 
Std. Deviation 5.562 1.097 0.5891 0.3271 0.4082 1.5 
Std. Error 2.271 0.4478 0.2405 0.1335 0.1667 0.6125 
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GROUP 
III 
Lymph        
(%) 
Mon            
(%) 
Neutrophils   
10
3
/mm3 
Eosinophi
ls (%) 
Basophil
s (%) 
MPV     
(fl) 
Mean 74.67 3.65 2.617 1.383 0.3333 5.967 
Std. 
Deviation 5.923 1.071 0.736 0.2994 0.5164 1.289 
Std. Error 2.418 0.4372 0.3005 0.1222 0.2108 0.5264 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett‟s test. 
Effect of Chitramutti Nei on Serum Bio-chemistry profile of rats in sub-acute 
toxicity study 
GROUP I 
Blood 
sugar  
(mg/dl) 
BUN 
(mg/dl) 
Serum 
creatinine 
(mg/dl) 
Serum total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholester
ol (mg/dl) 
Serum 
LDL 
choleste
rol 
(mg/dl) 
Serum 
VLDL 
cholesterol 
(mg/dl) 
Mean 77 18.83 0.6833 117 74.33 69.17 31.33 16.45 
Std. 
Deviation 6.066 2.317 0.1722 4.942 5.888 3.545 5.007 2.971 
Std. Error 2.477 0.9458 0.07032 2.018 2.404 1.447 2.044 1.213 
GROUP II 
Blood 
sugar  
(mg/dl) 
BUN 
(mg/dl) 
Serum 
creatinine 
(mg/dl) 
Serum total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholester
ol (mg/dl) 
Serum 
LDL 
choleste
rol 
(mg/dl) 
Serum 
VLDL 
cholesterol 
(mg/dl) 
Mean 78.67 17.33 0.75 108.7 77.67 60.67 32.17 15.88 
Std. 
Deviation 7.528 4.367 0.1871 7.913 7.339 5.502 9.786 2.003 
Std. Error 3.073 1.783 0.07638 3.23 2.996 2.246 3.995 0.8179 
GROUP III 
Blood 
sugar  
(mg/dl) 
BUN 
(mg/dl) 
Serum 
creatinine 
(mg/dl) 
Serum total 
cholesterol 
(mg/dl) 
Serum 
triglycerides 
level (mg/dl) 
Serum 
HDL 
cholester
ol (mg/dl) 
Serum 
LDL 
choleste
rol 
(mg/dl) 
Serum 
VLDL 
cholesterol 
(mg/dl) 
Mean 86.83 16.17 0.8333 115.1 74.83 64.67 32.83 17.55 
Std. 
Deviation 13.92 3.869 0.216 7.234 7.36 7.367 10.15 3.257 
Std. Error 5.683 1.579 0.08819 2.953 3.005 3.007 4.143 1.33 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett‟s test. 
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Effect of Chitramutti Nei on Serum Bio-chemistry profile of rats in sub-acute 
toxicity study 
GROUP I 
Serum 
total 
protein 
(g/dl) 
Serum 
albumin 
(g/dl) 
(AST)  
(IU/ml) 
(ALT)               
(IU/L) 
(ALP)         
(IU/L) 
Mean 6.35 3.6 102.3 36.5 112 
Std. Deviation 0.9995 0.08944 13.87 7.714 15.47 
Std. Error 0.408 0.03651 5.661 3.149 6.314 
GROUP II 
Serum 
total 
protein 
(g/dl) 
Serum 
albumin 
(g/dl) 
(AST)  
(IU/ml) 
(ALT)               
(IU/L) 
(ALP)         
(IU/L) 
Mean 6.467 3.667 100.2 28 137.7 
Std. Deviation 0.7062 0.4412 16.24 8.149 18.52 
Std. Error 0.2883 0.1801 6.63 3.327 7.562 
GROUP III 
Serum 
total 
protein 
(g/dl) 
Serum 
albumin 
(g/dl) 
(AST)  
(IU/ml) 
(ALT)               
(IU/L) 
(ALP)         
(IU/L) 
Mean 6.7 3.883 96.17 27.17 117.5 
Std. Deviation 0.743 0.4708 13 8.704 23.56 
Std. Error 0.3033 0.1922 5.307 3.554 9.619 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females). Control and 
treatment groups were compared statistically using one way ANOVA followed by 
Dunnett‟s test. 
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Quantitative data on absolute organ weight of rats treated with Chitramutti Neifor 28 
days in Sub-acute toxicity study. 
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Mean 0.7683 5.948 1.617 0.5667 1.483 1.6 1.15 1.833 0.8667 
Std. 
Deviation 0.05636 0.9834 0.2137 0.1633 0.1472 0.3162 0.501 0.4933 0.4041 
Std. Error 0.02301 0.4015 0.08724 0.06667 
0.0600
9 0.1291 0.2045 0.2848 0.2333 
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Mean 0.5767 5.183 1.6 0.6167 1.45 1.467 0.7667 2.033 0.7667 
Std. 
Deviation 0.155 0.9404 0.1414 0.1472 0.1871 0.3077 0.1211 0.3215 0.3786 
Std. Error 0.06328 0.3839 0.05774 0.06009 
0.0763
8 0.1256 0.04944 0.1856 0.2186 
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Mean 0.6583 5.718 1.567 0.6333 1.55 1.483 1 3.167 0.9333 
Std. 
Deviation 0.2088 1.055 0.2338 0.216 0.1643 0.2401 0.3521 0.3215 0.4933 
Std. Error 0.08526 0.4309 0.09545 0.08819 
0.0670
8 0.09804 0.1438 0.1856 0.2848 
 
 
Values are mean ± S.D (n = 6 per group of which 3 males and 3 females) for Heart, 
Liver, Kidney, Brain, Spleen, Lung, Stomach.   Values are mean ± S.D (n = 3 per 
group per sex ) for testes , ovary and uterus for Control and treatment groups were 
compared statistically using one way ANOVA followed by Dunnett‟s test. 
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ANNEXURE –V 
PHARMACOLOGICAL STUDY 
A.HAEMATINIC ACTIVITY 
 
Name Dr.G.G.KALAISELVI 
IAEC SU/CLATR/IAEC/VII/043/2016 
Name of the 
Formulation Chitramutti Nei 
Abbreviation CN 
 
 Aim: 
 To find out the Haematinic activity of Chitramutti Nei in female Swisss albino 
rats 
Preparation of Stock Solution 
The suspension of CN was prepared by mixing with water at a concentration 
of 200 mg/ml stock solution. The solution was administered orally by gastric 
intubation in rats. 
Animals: 
Female Swiss albino rats weighing about 230-250 gm were obtained from the 
animal house of Sathyabama University, Chennai. The animals were acclimated to 
standard laboratory condition (temperature – 24 to 28C and humidity 60- 70%) and 
maintained on 12 hr light/ dark cycle. The animals were housed in polypropylene 
cages and fed with standard rodent pellet obtained and water ad libitum.  
 Evaluation of the Haematinic activity: 
Anaemia was induced in rats by administrating a single intraperioneal 
injection of phenyl hydrazine at a dose of 20 mg/kg b.w. Drop out period of four days 
was awaited until the sufficient drop in Hb level was noticed in animals. Rats were 
considered as anaemic model if haemoglobin concentration was less than 14g/dl.  
From day 5 to day 19, the test drug was administered orally at two different doses 
(100mg/kg, 200mg/kg). On day 20 blood was collected by retro orbital puncture for 
haematological evaluation and the blood parameters were analysed. 
 
Group I – treated as negative control (phenyl hydrazine induced anaemic rats) 
administered vehicle only. 
133 
 
 
 
Group II– Animal injected with phenyl hydrazine 20mg/kg + treated with test drug 
100 mg/kg, p.o. (Low dose Group) 
Group III– Animal injected with phenyl hydrazine 20mg/kg + treated with test drug 
200 mg/kg, p.o. (High dose Group) 
Group IV- Considered as positive control administered standard haematinic syrup. 
HAEMATOLOGICAL INVESTIGATIONS: 
The blood samples form negative control and drug treated rats were collected 
into heparinized tubes after 14 days treatment (on day 20) and parameters such as 
haemoglobin count, red blood cells (RBC), packed cell volume (PCV), Mean 
corpuscular volume (MCV), mean corpuscular haemoglobin (MCH) were analysed. 
 
Haematological Parameters of Rats after Treatment with CN. 
 
PHZ RBC                  
(×10 
6
 µl) 
PCV                  
% 
MCV                       
(fl) 
MCH                
(pg) 
MCHC          
(g/dl) 
HGB         
(g/dl) 
Mean 4.27 38.44 40.90 12.05 26.07 10.68 
Std. 
Deviation 
0.21 0.58 0.41 0.195 0.213 0.40 
Std. Error 0.08 0.24 0.16 0.079 0.086 0.166 
GROUP II 
CN(100mg) 
RBC                  
(×10 
6
 µl) 
PCV                  
% 
MCV                       
(fl) 
MCH                
(pg) 
MCHC          
(g/dl) 
HGB         
(g/dl) 
Mean 6.168 43.79 46.05 13.23 31.57 13.05 
Std. 
Deviation 
0.244 0.259 0.440 0.261 1.372 1.495 
Std. Error 0.09 0.10 0.17 0.10 0.5602 0.6103 
GROUP III 
CN(200mg) 
RBC                  
(×10 
6
 µl) 
PCV                  
% 
MCV                       
(fl) 
MCH                
(pg) 
MCHC          
(g/dl) 
HGB         
(g/dl) 
Mean 6.708 47.738 55.49 17.56 32.77 14.98 
Std. 
Deviation 
0.170 0.219 0.182 0.183 1.581 0.133 
Std. Error 0.069 0.089 0.182 0.074 0.6453 0.135 
STANDARD 
 
RBC                  
(×10 
6
 µl) 
PCV                  
% 
MCV                       
(fl) 
MCH                
(pg) 
MCHC          
(g/dl) 
HGB         
(g/dl) 
Mean 6.988 51.90 74.378 27.95 33.891 21.8 
Std. 
Deviation 
0.144 0.184 0.203 0.189 0.201 0.456 
Std. Error 0.059 0.075 0.083 0.077 0.08 0.186 
Values are expressed as mean+SEM (Dunnet„t‟ test) *p<0.05; **p<0.01 vs control n=6.  
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Statistical Analysis: 
The statistical analysis was carried by one way ANOVA (GRAPH PAD PRISM 5 
computer program). Results are expressed as mean ± standard error. A statistical 
comparison was carried out using the Dunnets 't' multiple comparison test for 
comparing control and treatment group.P value less than 0.05 considered as 
statistically significant 
 
B. ANTI-HELMINTHIC ACTIVITY OF THE STUDY DRUG CN 
Project Id: NRS/AS/0018/01/2017 
Total Sample: 01  
Sample ID: CN 
Institute: Govt Siddha Medical College, Chennai 
Dose Equivalent of Test drug = 1ml is equivalent to 1.02085 gm 
 
Earthworm  
Indian adult earthworms (Pheretimaposthuma) were  collected from moist soil and 
washed with normal saline were used for the anthelmintic study. The earthworms of 
4-6 cm in length and 0.1-0.2 cm in width were used. 
Procedure 
 The worms were acclimatized to the laboratory condition one week prior to 
the experimentation. The earthworms were divided into three groups of four 
earthworms in each group of two per petri dish. Albendazole at the concentration of 
100mg/ml was served as standard.Clean and sterile petri plates were used for the 
study. Group I served as low dose treated group of which the worms were exposed to 
10ml of the test formulation weight equivalent to 10gms and Group II served as high 
dose treated group of which the worms were exposed to 20ml of the test formulation 
weight equivalent to 20gms . Group III served as standard drug treated group of 
which the worms were exposed toAlbendazole 100mg/ml. 
GROUPING 
Group I – Worms exposed to CN 10ml 
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Group II – Worms exposed to CN 20ml 
Group III – Worms exposed to Albendazole 100mg/ml 
Observation 
Earthworms of nearly equal size in length and width are taken for each 
concentration and placed in Petri dishes at room temperature. The time taken for 
complete paralysis and death are recorded. The mean paralysis time and mean death 
time for each  dose was calculated .The time  taken for worms to become motionless 
was noted as paralysis time  and to ascertain death, each worm was frequently applied 
with external stimuli, which stimulates and induce movement in the  earthworms. 
Group Concentration Man/SD 
Time taken  
for paralysis  
(min) 
Time taken  
for death  
(min) 
I 10gms Mean 149 303.3 
    
Std. 
Deviation 15.34 6.898 
    Std. Error 7.67 3.449 
          
II 20gms Mean 120.5 260.5 
    
Std. 
Deviation 8.544 20.16 
    Std. Error 4.272 10.08 
          
III 
Albendazole 
100mg/ml Mean 50.5 88 
    
Std. 
Deviation 14.48 7.303 
    Std. Error 7.24 3.651 
 
RESULT ANALYSIS 
The result obtained from the present clearly indicates that the test drug CN has 
anti-helminthic property. Maximum time take for the test drug CN to cause paralysis 
of worms is about149 ± 15.3 mins, similarly the time taken of CN at the of 20gm 
would be 120.5 ± 8.54 mins for standard drug albendazole it was50.5 ± 14.4mins at 
the concentration of 100mg/ml. 
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Maximum time take for the test drug CN to cause death of worms is about 
303.3± 6.89mins, similarly the time taken of CN at the dose of 20gm would be 260.5 
± 20.16mins for standard drug albendazole it was 88± 7.30mins at the concentration 
of 100mg dose /ml. 
CONCLUSION 
From the result of the study it was concluded that the test drug CN possess 
convincing anthelmintic property. 
                
                 Group I                                                    Group II 
      
 
 
 
 
 
 
 
 
GROUP III 
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                                                     ANNEXURE-VI 
BIO-STATISTICS  
Treatment for Paandu Noi: 
The most popular non parametric statistical tool, namely, McNemar Test 
analysis has been employed to analyses the effectiveness with the help of a 
hypothesis. 
 
S. 
No 
Signs&Symptoms Before Treatment After Treatment 
n% n% 
1. Pallor of conjunctivae, 
tongue, nail beds 
40(100) 10(25)** 
2. Anorexia 40(100) 0(0)** 
3. Fatigue / Lassitude 40(100) 4(10)** 
4. Constipation 26(65) 3(8)** 
5. Lack of interest & 
concentration 
16(40) 6(15)* 
6. Dyspnoea on exertion 15(38) 2(5)* 
7. Weight loss 17(43) 2(5)* 
McNemat test, C.I: 95%,  *P<0.05; **P<0.01 
Software: spss17 version 
Number of cases: 40 
Inference:  
Since the p value is significant in all signs and symptoms So there is 
significant reducing of signs & symptoms except dimness of vision among the 
patients for the treatment of Paandu Noi.Hence it is concluded that the treatment was 
effectiveand significant.  
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HAEMOGLOBIN  LEVEL: 
Software: spss17 version 
Variables: Hb level (gm/dl)– before treatment, after treatment 
Number of cases: 40 
Test: Paired t test 
Confidence Interval: 95% 
Correlation coefficient (r): 0.500 
Before and after treatment mean difference ± SEM: 1.98± 0.15. 
P Value (2 tailed): p<0.001. 
Inference:  
Since the P value is highly significant (<0.001), So the treatment was 
significantly improving the Hb level among the patients for the treatment of Paandu 
Noi.  
 
 
 
 
  
139 
 
 
 
ANNEXURE -VII 
GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “CHITRAMUTTI NEI” IN THE TREATMENT OF 
“PAANDU NOI‟‟ (IRON DEFICIENCY ANAEMIA) IN CHILDREN 
FORM l - SCREENING AND SELECTION PROFORMA 
1.OP NO :  ............................................................................ 
2.NAME :  …………………………………………...........  
3.AGE :      ………        4.GENDER :  …………....... 
5. F.OCCUPATION :………………………………  
6.F.INCOME:   ………………… 
7. ADDRESS :   …………………………………….............  
……………………………………............ 
……………………………………........... 
8. CONTACT NO:   …………………………………… 
 INCLUSION CRITERIA: 
 Age :  3-12 Yrs                                              Yes/ No 
 Hb 7-11 gm        Yes/ No 
 Patient having sign of pallor in  conjunctivae, tongue, Nail bud  Yes/ No    
 Patient having symptoms of fatigue , Anorexia, dyspnoea on exertion    
         Yes / No                      
 Loss of memory/ lack of concentration    Yes/ No 
 Patient suffering from worm infestation    Yes/ No 
 Patients who are willing to undergo laboratory investigation. Yes/No 
 Patients who are willing to sign the informed consent stating that she will 
continuously stick to the treatment during 28days but can opt out of the trial of 
her own conscious discretion.                                  Yes/No     
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EXCLUSION CRITERIA 
(Clinical history) 
 History of Metabolic disorder 
 History of Haemolytic anaemia 
 Patient with chronic disease 
 Patient with any other serious illness 
 
ADMITTED TO TRIAL: 
 
 YES                        NO                 
 
    If yes,                       OPD/IPD                    
 
Date:        
Station: 
 
 
Signature of the Guide                                 Signature of the Investigator   
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “CHITRAMUTTI NEI” IN THE TREATMENT OF   
            “PANNDU NOI‟‟ (IRON DEFICIENCY ANAEMA) IN CHILDREN 
FORM II -HISTORY TAKING PROFORMA 
1. SERIAL NO. OF THE CASE: ……...... 2.OP/IP NO: 
................................................  
3. NAME: ………………………………………… 4. AGE: …….......  
5. GENDER: ……......... 
5.F.OCCUPATION: ………………………     
6.F. INCOME:   …………………....... 
7.COMPLAINTS& DURATION:   
 
8. PERSONAL HISTORY:                                                                                                                                  
9. HISTORY OF PREVIOUS ILLNESS: 
10. BIRTH HISTORY: 
11. DIETARY HABIT: 
1.Vegetarian 
2.Non-vegetarian 
12. FAMILY HISTORY: 
               Whether this problem runs in family? 
  1. Yes                               2.No        
If yes, mention the relationship of affected person(s) _________________________ 
History of previous investigations if any __________________________ 
 
Date:        
Station            
 
Signature of the Guide                              Signature of the Investigator 
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GOVERNMENT SDIDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “CHITRAMUTTI NEI” IN THE TREATMENT OF  
         “PAANDU NOI‟‟ (IRON DEFICIENCY ANAEMIA)IN CHILDREN 
 
FORM III ASSESSMENT PROFORMA 
 
1.SERIAL NO: …………………......... 
2.OP / IP NO: ........................................................  
3. NAME: ……………………………........   4.AGE: …….....      
5.GENDER: .................            
 
GENERAL EXAMINATION: 
Height (cms)                : ………………………….                   
Weight (kg)    : ………………………….                   
Temperature(°F)     : ………………………….                   
Pulse rate(/min)   : ………………………….                   
Heart rate(/min)   : ………………………….                   
Respiratory rate(/min)  : ………………………….                   
Blood pressure(mm/Hg)      : ………………………….      
 
   Present          Absent 
Pallor  
Jaundice 
Cyanosis 
Lymphadenopathy 
Pedal edema 
Clubbing 
Jugular vein pulsation 
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SYSTEMIC EXAMINATION 
CardioVascular System  : ………………………….                   
Respiratory system   : ………………………….                   
Gastro-intestinal system  : ………………………….                   
Central Nervous System  : ………………………….                   
Urogenital system   : ………………………….                   
Endocrine System   : ………………………….                   
SIDDHA SYSTEM OF EXAMINATIONS: 
1. THEGI:  [BODY CONSTITUTION]  
1. Vatha udal 
2. Pitha udal 
3. Kaba udal 
4. Thontha udal  
2. NILAM:  [LAND WHERE PATIENT LIVED MOST] 
1. Kurinji    (Hilly terrain)                                   
2. Mullai    (Forest range)                       
3. Marutham    (Plains)                            
 4. Neithal     (Coastal belt)                    
5. Paalai  (Arid regions) 
3. KAALAM: 
1. Kaar kaalam                               4.Pinpani kaalam      
2. Koothir kaalam                           5. Ilavenil kaalam 
3. Munpani kaalam                           6.Muthuvenil kaalam 
4. GUNAM: 
1.Sathuvam 2.Raasatham             3.Thaamatham 
5. IMPORIGAL (SENSORY ORGANS): 
Normal/Affected 
Mei  ----------------------------------------------- 
Vaai  ----------------------------------------------- 
Kann  ------------------------------------------------ 
Mukku ------------------------------------------------ 
Sevi  ------------------------------------------------ 
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6. KANMENDHIRIYAM (MOTOR ORGANS): 
Kai  ----------------------------------                
Kal  ------------------------------------ 
Vaai   ------------------------------------ 
Eruvai ---------------------------------- 
Karuvaai --------------------------------- 
7. KOSANGAL (SHEATH): 
Annamaya kosam ------------------------ 
Pranamaya kosam -------------------------- 
Manomaya kosam ------------------------------- 
Vignana maya kosam ----------------------------- 
Anandamaya kosam ------------------------------- 
8. UYIR THAATHUKKAL: [THREE HUMORS] (VALI, AZHAL, IYAM) 
A) VALI 
 Pranan ________________________  
Abanan ________________________ 
Samanan ________________________  
Uthanan ________________________  
Vyanan ________________________  
Naagan ________________________  
Koorman ________________________ 
Kirukaran ________________________ 
Devathathan  ________________________ 
Dhananjayan ________________________ 
B) AZHAL 
Analakam ________________________ 
Ranjakam ________________________ 
Sathakam ________________________ 
Prasakam  ________________________ 
Alosakam  ________________________ 
C) IYAM 
Avalambagam _______________________ 
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Kilethagam __________________________ 
Pothagam  __________________________ 
Tharpagam  __________________________ 
Santhigam __________________________ 
9. SEVEN UDAL THATHUKKAL: (SEVEN SOMATIC COMPONENTS) 
Saram  ___________________________ 
Senneer ___________________________ 
Oon   ___________________________ 
Koluppu  ___________________________ 
Enbu   ___________________________ 
Moolai  ___________________________ 
Sronitham  ___________________________ 
10. ENVAGAI THERVU: 
I. NAADI: [PULSE PERCEPTION]         
II. SPARISAM: [PALPATION] 
III. NAA: [TONGUE] 
 IV. NIRAM: [COMPLEXION]   
1. Vadham         
2. Pitham 
3. Kabam  
V. MOZHI: [VOICE] 
1. High Pitched 
            2. Low Pitched 
3. Medium Pitched 
VI. VIZHI: [EYES] 
VII. MALAM: [BOWEL HABITS / STOOLS] 
Niram 
Irugal 
Ilagal 
Others 
VIII. MOOTHIRAM [URINE EXAMINATION]   
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NEERKKURI: 
Niram 
Manam 
Edai 
Nurai 
Enjal 
NEIKKURI: 
 
 
 
Date:      
Station: 
 
 
Signature of the Guide                            Signature of the Investigator   
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
POST- GRADUATE DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
 
CLINICAL STUDY ON “CHITRAMUTTI NEI” IN THE TREATMENT OF 
“PAANDU NOI‟‟ (IRON DEFICIENCY ANAEMIA)IN CHILDREN 
 
FORM IV:  LABORATORY INVESTIGATIONS PROFORMA 
1. SERIAL NO. OF THE CASE:  ………........ 
2.OP / IP NO: ......................................   
3. NAME: ……………………………   4.AGE: ……     5.GENDER: .................   
 
A) BLOOD INVESTIGATIONS: 
  
BLOOD INVESTIGATIONS 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Hb (gm/dL)   
T.RBC (millions cells/ Cu.mm)   
ESR (mm) ½ hr.   
 1 hr.   
T.WBC (Cells / Cu.mm)   
Differential 
Count (%) 
Polymorphs 
  
 Lymphocytes   
 Monocytes   
 Eosinophils   
 Basophils   
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[ 
INVESTIGATIONS 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Motion Ova   
 
Cyst   
 
B) URINE INVESTIGATIONS: 
URINE INVESTIGATIONS 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Albumin   
Sugar   
Deposits   
 
Date:          
Station: 
 
Signature of the Guide                                            Signature of the Investigator   
 
BLOOD INVESTIGATIONS 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
PCV   
MCV   
MCH   
MCHC   
SERUM IRON   
SERUM FERRITIN   
TIBC   
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “CHITRAMUTTI NEI” IN THE TREATMENT OF                  
“PAANDU NOI‟‟ (IRON DEFICIENCY ANAEMIA)IN CHILDREN 
FORM V: INFORMED CONSENT FORM 
 
“I have read the foregoing information, or it has been read to me. I have the 
opportunity to ask questions about it to my satisfaction. 
            I consent voluntarily to participate my child in this study and understand that 
I have the right to withdraw my child from the study at any time without in any 
way it affecting my child further medical care”. 
"I have received a copy of the information sheet/consent form". 
Date: 
Signature of the participant: 
 
In case of illiterate participant 
  “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has the opportunity to ask questions. I confirm that 
the individual has given consent freely.”                                                   
Date: 
Signature of a witness                                    Left thumb Impression of the Participant     
(Selected by the participant bearing no connection with the survey team)       
Date:    
Station:                                                                                  
Signature of participant:                                                 
Signature of the Guide                                      Signature of the Investigator:   
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muR rpj;j kUj;Jtf; fy;Y}Hp> nrd;id-106 
mwpQh; mz;zh kUj;Jtkid> nrd;id 
ghz;L Neha;f;fhd rpj;j kUe;jpd; (rpw;whKl;b nea;) 
 ghpfhpg;Gj; jpwidf; fz;lwpAk; kUj;Jt Ma;tpw;fhd jfty; gbtk;;Xg;Gjy; 
gbtk; Ma;thsuhy; rhd;wspf;fg;gl;LJ. 
     ehd; ,e;j Ma;it Fwpj;j midj;J tpguq;fisAk; Nehahspf;F GupAk; 
tifapy; vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
Njjp:                            ifnahg;gk;: 
,lk;:                            ngah;:  
Nehahspapd; ngw;Nwhh; xg;Gjy; gbtk;  
     vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk;> kUe;jpd; jd;ik kw;Wk; 
kUj;Jt topKiw gw;wpAk;> njhlh;e;J vdJ cly; ,af;fj;ij 
fz;fhzpf;fTk;> mjid ghJfhf;fTk;; gad;gLk; kUj;Jt Ma;Tf;$l 
ghpNrhjidfs; gw;wp jpUg;jp mspf;Fk; tifapy; Ma;T kUj;Jtuhy; tpsf;fpf; 
$wg;gl;;lJ. 
     ehd; vdJ Fo;e;ijapd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; 
$whky;> vg;nghOJ Ntz;LkhdhYk ,e;j Ma;tpypUe;J vdJ Foe;ijia 
tpLtpj;J nfhs;Sk; cupikia njupe;jpUf;fpd;Nwd;. ehd; vd;Dila 
Rje;jpukhf Njh;T nra;Ak; cupikiaf; nfhz;L Neha;f;fhd rpw;whKl;b nea; 
kUe;jpd; ghpfhpg;Gk; jpwidf; fz;lwpAk; kUj;Jt Ma;tpw;F vd;id cl;gLj;j 
xg;Gjy; mspf;fpNwd;.  
Njjp:                            ifnahg;gk;: 
,lk;:                            ngah;:  
 
Njjp:                            rhl;rpf;fhuh; ifnahg;gk;: 
,lk;:                            ngah;:  
cwTKiw: 
 
Jiwj;jiyth; ifnahg;gk;:           Muha;r;rpahsh; ifnahg;gk;:   
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GOVERNMENT SIDDHA MEDICAL COLLEGE, CHENNAI 
CLINICAL STUDY ON “CHITRAMUTTI NEI” IN THE TREATMENT OF 
“PAANDU NOI‟‟ (IRON DEFICIENCY ANAEMIA) IN CHILDREN 
FORM VI - WITHDRAWAL FORM 
SI NO  : 
OP / IP NO :                                               
NAME : 
AGE / GENDER: 
DATE OF TRIAL COMMENCEMENT  : 
DATE OF WITHDRAWAL FROM TRIAL : 
REASONS FOR WITHDRAWAL: 
• Long absence at reporting :                                  Yes/ No 
• Irregular treatment:                                            Yes/ No 
• Shift of locality :                                                Yes/No 
• Increase in severity of symptoms:                         Yes/No 
• Development of severe adverse drug reactions:    Yes/No 
 
 
Date:          
Station: 
 
Signature of the Guide                                                 Signature of the Investigator   
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “CHITRA MUTTI” IN THE TREATMENT OF 
“PAANDU NOI‟‟ (IRON DEFICIENCY ANAEMIA) IN CHILDREN 
FORM VII – PATIENT INFORMATION SHEET 
Name of Co- Investigator:  G.G. Kalaiselvi                
Name of the college: 
 Govt. Siddha Medical  College, Arumbakkam, Chennai-106. 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL. 
 I, G.G.Kalaiselvi studying M.D(Siddha) at Govt.Siddha Medical College, 
Chennai, is doing a clinical trial on „„PAANDU Noi” –Iron Deficiency Anaemia in 
children. It is becoming a most common disease, occurring throughout the world. In 
this regard, I am in need to ask you few questions. I will maintain confidentiality of 
your comments and data obtained. There will be no risk of disclosing your identity 
and no physical, psychological or professional risk is involved by taking part in this 
study. Taking part in this study is voluntary. No compensation will be paid to you for 
taking part in this study. 
 You can choose not to take part. You can choose not to answer a specific 
question. There is no specific benefit for you if you take part in the study. However, 
taking part in the study may be of benefit to the community, as it may help us to 
understand the problem of defaulters and potential solutions. 
 If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal 
medicine„„Chitramutti Nei" (Internal medicine) 4-5 ml (B.D) for 28 days.  
  The information I am collecting in this study will remain between you and the 
Co- investigator (myself). I will ask you few questions through a questionnaire. I will 
not write your name on this form. I will use a code instead. 
 The questionnaire will take approximately 20 minutes of your time. 
 If you wish to find out more about this study before taking part, you can ask 
me all the questions you want or contact G.G.Kalaiselvi, PG Scholar cum Co- 
investigator of this study, attached to Govt. Siddha Medical College, Chennai-106. 
You can also contact the Member-secretary of Ethics committee, Govt. Siddha 
Medical College, Chennai. 
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muR rpj;j kUj;Jtf; fy;Y}Hp> nrd;id-106 
mwpQh; mz;zh kUj;Jtkid> nrd;id 
ghz;L Neha;f;fhd rpj;j kUe;jpd; (rpw;whKl;b nea;) 
ghpfhpg;Gj; jpwidf; fz;lwpAk; kUj;Jt Ma;tpw;fhd jfty; gbtk; 
 
Muha;r;rpahsh; ngau;: Nfh.Qh.fiyr;nry;tp 
epWtdj;jpd; ngau;:muR rpj;j kUj;Jtf; fy;Y}up 
mUk;ghf;fk;> nrd;id-106 
     muR rpj;j kUj;Jtf; fy;Y}upapy; gl;lNkw;gbg;G gapd;W tUk; ehd; 
kUj;Jtu; Nfh.Qh.fiyr;nry;tp ghz;L vd;Dk; Nehapy; kUj;Jt Muha;r;rpapy; 
<Lgl;Ls;Nsd;. 
 ,e;j Neha; cl;lr;rj;J Fiwtpdhy; Vw;gLfpd;wd. ,J gutf; $ba 
Nehay;y. 
,e;j Muha;r;rp rk;ge;jkhf rpy Nfs;tpfisf; Nfl;fTk;> Njitahd 
Ma;tfg; gupNrhjidf;F jq;fs; Foe;ijia cl;gLj;jTk cs;Nsd;. 
 
,e;j Muha;r;rpf;F jq;fs; tpUg;gj;jpd; Ngupy; cl;gLk; gl;rj;jpy; 
cs;kUe;ehf rpw;whKl;b nea; 4-5 kpyp 2 Ntis (fhiy> khiy) czTf;F 
gpd; 28 ehl;fs; cl;nfhs;s Ntz;Lk;. ntspNehahsh;fs; 7 ehl;fSf;F xU 
Kiw tuNtz;Lk;.  
    ,e;j kUe;J rpwg;ghf ghz;L Neha;f;fhf mq;fPfupf;fg;gl;l rpj;j kUj;Jt 
E}ypy; $wg;gl;Ls;sJ  
    ,e;j Muha;r;rpapy; jq;fis mDkjpj;j gpwF cq;fSf;F tpUg;gk; 
,y;iynadpy; vg;NghJ Ntz;LkhdhYk; Muha;r;rpapy; ,Ue;J tpyfpf; nfhs;s 
cupik cs;sJ. 
,e;j Muha;r;rpf;F rk;ge;jkhf Nehapd; jd;ik gw;wpAk; kw;w 
tpguq;fSf;Fk; Muha;r;rpahsu; kUj;Jtu;: Nfh.Qh.fiyr;nry;tp (gl;lNkw;g; 
gbg;ghsu;> Foe;ij kUj;Jtj; Jiw) mtu;fis ve;j Neuj;jpYk; njhlu;G 
nfhs;syhk;. ifg;Ngrp vz;: 9500738302.  
     NkYk; ,e;j Muha;r;rpf;F jf;f mDkjpr; rhd;W (IEC) 
ngwg;gl;Ls;sJ. 
     ,e;j kUe;J Kw;wpYk; ghJfhg;ghd %ypif nghUl;fisf; nfhz;L 
jahhpf;fg;gl;Ls;sJ. gf;f tpisTfis Vw;gLj;jhJ. NkYk; czT Kiwapy; 
kUj;Jtuhy; $wg;gLk; gj;jpak; fhf;FkhW mwpTWj;jgLfpwJ. 
,J rk;gjkhd jq;fsJ midj;J tptuq;fSk; ufrpakhf itf;fg;gLk; 
vd cWjp mspf;fpNwd;. 
 ,jpy; gazg;gb Kjypa ve;j cjtpj; njhifAk; toq;fg;glkhl;lhJ. 
 ,e;j Muha;r;rpapd; NghJ clYf;F NtW ghjpg;G Vw;gLk; gl;rj;jpy; 
mwpQu; mz;zh kUj;Jtkidapy;> jf;f rpfpr;ir mspf;fg;gLk;. 
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GOVERNMENT SIDDHA MEDICAL COLLEGE 
ARIGNAR ANNA GOVERNMENT HOSPITAL OF INDIAN MEDICINE 
CHENNAI – 600 106 
CLINICAL STUDY ON “CHITRAMUTTI NEI” IN THE TREATMENT OF 
“PAANDU NOI‟‟ (IRON DEFICIENCY ANAEMIA)IN CHILDREN 
FORM X - ADVERSE REACTION REPORTING FORM 
 
SERIAL NO :                                                                                                           
OP/IP NO : 
NAME :                                                     AGE:                 GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF OCCURRENCE OF THE ADVERSE REACTION:  
TIME: 
DESCRIPTION OF ADVERSE REACTION: 
 
MANAGEMENT: 
 
 
 
Date:                                                                              
Station: 
 
 
 
Signature of the Guide                                   Signature of the Investigator   
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DEPARTMENT OF KUZHANTHAI MARUTHUVAM 
DISSERTATION STUDY ON CHITRAMUTTI NEI IN  
PAANDU NOI (IRON DEFICIENCY ANAEMIA) 
INVESTIGATOR – Dr. G.G.KALAISELVI 
ANNA HOSPITAL OPD- CHENNAI-106 
OP.NO:                                                                                     DATE: 
NAME:                                                                                      
AGE / SEX: 
PARENT NAME: 
ADDRESS: 
 
PHONE NO: 
COMPLAINTS & DURATION: 
 Loss of appetite 
 Fatigue  
 Worm infestation 
 Dyspnoea on exertion 
 Pallor of skin and mucous membrane 
 Lack of concentration 
ECONOMIC STATE  :          POOR / MIDDLE / RICH 
DIET    :          VEG / MIXED 
H/O PICA    :  
FAMILY HISTORY  : 
PAST HISTORY  : 
 
ON EXAMINATION: 
HT   :   
WT   :                           
PALLOR  : 
CVS   : 
RS   : 
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ENVAGAI THERVU: 
NAA  :   MALAM  : 
NIRAM :   MOOTHIRAM : 
MOZHI :   NAADI  : 
VIZHI  :   SPARISM  : 
INVESTIGATION: 
 BEFORE AFTER  BEFORE AFTER 
BLOOD   S.FERRITIN   
TC   TIBC   
DC   URINE   
ESR   Alb   
Hb   Sugar   
RBC   Dep   
PCV   MOTION   
MCV   OVA   
MCH   CYST   
MCHC      
 TREATMENT: 
 
 
 
 
 
 
 
 
 
WEEKS/ 
DATE 
Pallor 
Worm 
Infestation 
Loss Of 
Appetite 
Dyspnoea 
On 
Exertion 
Fatigue 
Lack Of 
Concentration 
I.        
II.        
III.        
IV.        
V.        
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GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL 
CHENNAI 
Branch -IV KUZHANTHAI MARUTHUVAM 
PROFORMA OF CASE SHEET FOR PAANDU NOI 
IP. No  :     Nationality  : 
Name   :     Religion  : 
Age   :     Date of Admission : 
Sex   :     Date of Discharge : 
Address    :     Diagnosis  : 
Informant  :     Medical Officer : 
1. Complaints and duration   : 
2. History of present illness   : 
3. History of Past illness   : 
4. Antenatal history   : 
5. Birth history    : 
6. Neonatal history    : 
7. Developmental  history   : 
8. Nutritional  history   : 
9. Immunization history   : 
10. Family history    : 
11. Socio economic status   : 
General examination: 
1. Appearance and posture   : 
2. Nutritional status    : 
3. Anaemia     : 
4. Cyanosis     : 
5. Clubbing     : 
6. Jaundice     : 
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7. Lymphadenopathy    :    
8. Abdominal distension    : 
9. Pedal oedema     : 
Vital Signs: 
1. Temperature  : 
2. Pulse rate   : 
3. Respiratory rate  : 
4. Heart rate   : 
5.  Blood pressure     : 
Anthropometry 
a. Height   : 
b. Weight   : 
c .Chest circumference : 
SIDDHA ASPECTS  
 Nilam 
1. Kurinji   : 
2. Mullai   : 
3. Marutham   : 
4. Neithal   : 
5. Paalai    : 
Paruvakalam 
1. Kaar    : 
2. Koothir   : 
3. Munpani   : 
4. Pinpani   : 
5. Elavenil   : 
6. Muthuvenil    : 
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Poripulangal   
1. Mei   : 
2. Vai   : 
3. Kan   : 
4. Mooku  : 
5. Sevi   : 
Kanmenthiriyam  
1. Kai   : 
2. Kaal   : 
3. Vaai   : 
4. Eruvai  : 
5. Karuvai  : 
Uyir thathukkal  
Vadham 
1. Praanan  : 
2. Abaanan  : 
3. Viyaanan  : 
4. Uthaanan  : 
5. Samaanan  : 
6. Naagan  : 
7. Koorman  : 
8. Kirukaran  : 
9. Devathathan  : 
10. Dhananjeyan  : 
Pitham 
1. Analpitham  : 
2. Ranjagam  : 
3. Saadhagam  : 
4. Praasagam  : 
5. Aalosagam  : 
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Kabam 
1. Avalambagam  : 
2. Kiletham  : 
3. Pothagam  : 
4. Tharpagam  : 
5. Santhigam  : 
UdalKattugal 
1. Saaram  : 
2. Senneer  : 
3. Oon  : 
4. Kozhuppu : 
5. Enbu  : 
6. Moolai  : 
7. Sukkilam / Suronitham:   
Envagai Thervugal 
1. Naadi  : 
2. Sparisam  : 
3. Naa  : 
4. Niram  : 
5. Mozhi  : 
6. Vizhi  : 
7. Malam  : 
8. Moothiram  : 
MODERN ASPECTS  
1. Respiratory System  : 
2. Cardiovascular system  : 
3. Gastro intestinal system : 
4. Central nervous system : 
5. Excretory system  : 
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Laboratory investigations  
Blood 
TC   : 
DC   : 
ESR  : 
1
/2 hr  : 
1 hr  : 
Hb%  : 
Urine 
 Albumin  : 
Sugar   : 
Deposits : 
Stools 
Ova  : 
Cyst  : 
Other Investigations 
PCV: 
MCV: 
MCH: 
MCHC: 
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Investigation - Siddha aspect 
 1. Neer kuri 
Niram   : 
Edai   : 
Manam  : 
Nurai   : 
Enjal   : 
2. Neikuri 
3. Daily progress 
Date Symptoms Medicine 
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9. ANNEXURE-I 
CERTIFICATES 
  
  
  
  

  
  
` 
  
HISTO PATHOLOGY REPORT 
BRAIN  
Arrangement of the neurons appears intact with no sings of degeneration or 
apoptotic changes were observed in sample belongs to group I,II and III. 
HEART  
Appearance of myocyte was normal. Myocardial tissue appears normal with 
orderly striated heart muscle fibers and a clear nuclear and muscle bands were 
observed in samples belongs to group I, II and III. 
LUNG  
Lung parenchyma appears normal with regular arrangement of alveoli and 
alveolar sac with no signs of lymphocyte infiltration and pulmonary fibrosis were 
observed in both control and treated rats. 
STOMACH  
The continuity of mucosa was normal with no evidence of ulceration. 
Mucosal wall appears normal with regular arrangement of connective tissue were 
observed in sample belongs to group I, II and III. 
LIVER  
The centrilobularhepatocytes  appears normal with stained cytoplasm. 
Appearance of portal vein, bile duct and hepatic artery was normal in sample belongs 
to group I, II and III. 
SPLEEN  
Erythropoietic cells (EP) are scattered throughout the red pulp of both the 
samples. No abnormalities found in lymph nodes of sample belongs to group I, II and 
III. 
 
KIDNEY  
Lumen of vessels and bowman’s space appears normal. No evidence of 
interstitial inflammation and lymphocyte accumulation were observed in in sample 
belongs to group I,II and III. 
TESTES  
Normal sertoli cell aligned properly on the basement membrane with oval 
dome shaped nucleus shows the normal morphology of the seminiferous tubule were 
observed in sample belongs to group I,II and III. 
UTERUS 
Appearance of endometrium, myometrium and uterine glands was normal. 
Arrangement of stratum basale, functionale and surface epithelium seems normal in 
samples belongs to group I,II and III. 
OVARY  
Histopathological analysis of ovary showing normal corpus luteum (CL) and 
Primordial follicles with few mature ovarian follicles with no signs of abnormality. 
Appearance of antral follicle, primary oocyte and secondary follicles are normal in 
sample belong to group I,II and III. 
  
RESULTS 
 
Test for Alkaloids        Test for CoumarinsTest for Saponins 
 
 
 
 
 
 
 
 
 
 
 
 
Test for Tanins           Test for Glycosides             Test for Flavonoids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Test for Phenols        Test for Cardiac Glycosides   Test for Steroids       Test for carbohydrate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Test for Terpenoids Test for Quinones Test for Proteins  Test for Anthocyanins 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Histopathological analysis (Female Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
Group I                         Group II                     Group III 
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Histopathological analysis (Female Rat) in Sub-acute toxicity Study 
High  Power Magnification 40X 
Group I                         Group II                     Group III 
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Histopathological analysis (Male Rat) in Sub-acute toxicity Study 
Low Power Magnification 10X 
Group I                         Group II                     Group III 
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Histopathological analysis (Male Rat) in Sub-acute toxicity Study 
High  Power Magnification 40X 
 Group I                               Group II                       Group III 
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